Protection against high fat diet induced obesity in mdx mice: is sarcolipin involved? by Kwon, Frenk
  
 
 
 
 
 
Protection against high fat diet induced obesity in mdx 
mice: is sarcolipin involved? 
by 
 
 
Frenk Kwon 
 
 
 
 
 
 
A thesis 
presented to the University of Waterloo 
in fulfillment of the 
thesis requirement for the degree of 
Master of Science 
in 
Kinesiology 
 
 
 
 
 
 
 
Waterloo, Ontario, Canada, 2018 
© Frenk Kwon 2018 
 
ii 
 
AUTHOR’S DECLARATION 
I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, 
including any required final reversions, as accepted by my examiners. 
 
I understand that my thesis may be made electronically available to the public. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
Abstract 
Sarcolipin (SLN) is a 31 amino acid proteolipid and one of the regulators of 
sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) pumps.  Previous research has shown that 
sarcolipin levels in muscles from wild type (WT) mice increase 2-3 fold in response to consuming 
a high fat diet, possibly to help mitigate obesity by increasing energy expenditure and burning 
excess calories. The role of SLN in diet-induced thermogenesis was shown in subsequent studies 
via high fat feeding of Sln-null mice.  In response to consuming a high-fat diet (HFD), Sln-null 
animals have significantly greater mass and adiposity, in addition to poorer glucose handling, 
compared with WT mice.  Higher than normal levels of SLN have also been found in mdx mice, a 
murine model of Duchenne muscular dystrophy.  Interestingly, it was reported that mdx mice are 
protected from obesity after high fat feeding.  The purpose of this thesis was two-fold: (1) to 
determine if mdx mice fed a Westernized diet are protected from diet-induced obesity, and (2) to 
determine the role of SLN in protecting mdx mice against diet-induced obesity.  WT, mdx, and 
mdx/Sln-null mice consumed a Westernized high-fat diet (42% kcal from fat) for 8 weeks while 
measurements of body weight and food consumption were made on a weekly basis.  Glucose 
tolerance testing (GTT) and measurements of whole body daily metabolic rate with the 
comprehensive laboratory animal monitoring system (CLAMS) were performed before and after 
the diet protocols.  Western blotting was conducted to determine the relative expression levels of 
SLN in diaphragm (DIA) and uncoupling protein (UCP)-1 in brown adipose tissue (BAT) from all 
animals.  Fat pads were collected to calculate relative adiposity to determine the level of obesity 
in all animals. As expected, in response to the high-fat diet, mdx but not mdx/Sln-null mice gained 
less weight and adiposity (P< 0.05) in comparison to WT mice.  Compared with mdx mice, 
mdx/Sln-null mice did not gain more weight but were more obese (P< 0.05) following the high-fat 
diet.  Whole body metabolic rate (ml O2/kg/hr) was higher (P< 0.05) in mdx mice in comparison 
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to WT and mdx/Sln-null mice before and after the high-fat diet, which may explain the lower diet-
induced obesity in mdx mice.  With increased obesity, mdx/Sln-null mice became extremely 
(P<0.05) glucose intolerant, more so than WT and mdx mice. Interestingly, mdx mice saw no 
change in glucose tolerance when compared with pre-HFD values, suggesting that mdx mice were 
protected from HFD-induced glucose intolerance. Western blotting analyses revealed SLN content 
was 2-fold higher in chow-fed mdx mice compared to chow-fed WT mice.  Although SLN 
expression in DIA remained higher in mdx compared with WT post-HFD, it decreased in response 
to the high-fat diet in mdx mice and was unchanged in WT mice.  UCP-1 expression was found to 
be higher (P<0.05) after the high-fat diet in all three genotypes, but there were no significant 
genotype differences in UCP-1 expression despite mdx/Sln-null mice having greater BAT weights 
compared with mdx mice.  Altogether, these results suggest that SLN could play a role in adaptive 
diet-induced thermogenesis in mdx mice and provide protection against diet-induced obesity and 
glucose intolerance.  However, despite the higher (P<0.05) daily VO2 in mdx compared to mdx/Sln-
null mice post-HFD, both saw a non-significant differences in absolute sleeping VO2 comparison 
to pre-diet values. Thus, it is possible that other thermogenic mechanisms may have caused the 
increase in resting VO2 of mdx/Sln-null mice.  
 
 
 
 
 
v 
 
Acknowledgements 
First and foremost, I must sincerely thank my supervisor, Dr. A. Russell Tupling, for giving 
me an opportunity to be part of such a wonderful laboratory. Your support and patience the last three 
years, through all the complications and tribulations has been greatly appreciated. Your support and 
mentorship have gotten me through this challenging journey and I cannot thank you enough for that. 
 I would also like to thank the rest of the Tupling laboratory for their support. This thesis would 
not have been completed without the guidance of Dr. Dan Gamu. Dan, your encouragement and “tough 
love” helped me get my project off the ground and your work ethic and determination in the two years 
we were working together provided me with a role model to hold myself to. Thank you for friendship 
and support and making things interesting and fun at the lab. To Cat, Emma, Paige, Reilly, Brad, Gabbi, 
Val, and Khan, you made me feel less like a cog in the laboratory machine but more as a member of 
an extended family. Your friendship is greatly appreciated, and I wish you all the best in your future 
endeavours.  
 Finally, I would like to thank my family for their support and love. This has been a difficult 
but rewarding journey and you have stood by me with words of encouragement as I pursued this 
Master’s degree. I am truly lucky to have such a large and supportive family. 
 
 
 
 
 
 
 
 
vi 
 
Dedication 
This thesis is dedicated to my father Jerry, mother Young Ju, uncle Joon, aunt Akane, and my 
dog Dol Dol. This experience has been at times stressful and difficult at times, but your love and 
support have helped get through this journey. This work is as much yours as it is mine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
Table of Contents 
AUTHOR’S DECLARATION………………………………………………………………….ii 
ABSTRACT……………………………………………………………………………………..iii 
ACKNOWLEDGEMENTS……………………………………………………………………..v 
DEDICATION…………………………………………………………………………………..vi 
List of Tables…………………………………………………………………………………......ix 
List of Figures………………………………………………………………………………….....x 
Introduction……………………………………………………………………………………....1 
Calcium Regulation and Thermogenesis ……………...........……………………………..1 
 Adaptive Thermogenesis and Sarcolipin…………………………………………………..3 
 Duchene Muscular Dystrophy and Sarcolipin……………………………………………..7 
 High Fat Feeding and mdx mice……………………………………………………….....10 
 Statement of the Problem………………………………………………………………...11 
 Research Objectives……………………………………………………………………...11 
 Hypotheses……………………………………………………………………………….11 
Methods………………………………………………………………………………………….12 
 Experimental Animals……………………………………………………………………13 
 Experimental Design……………………………………………………………………..14 
 Whole Body Metabolic Rate Measures…………………………………………………..14 
 Whole body glucose tolerance tests………………………………………………………15 
 Tissue Collection………………………………………………………………………....15 
 Western Blot Analyses…………………………………………………………………...16 
 Statistical Analyses…………………………………………………………………....…16 
Results…………………………………………………………………………………………...17 
 Body Weight……………………………………………………………………………..17 
viii 
 
 Adiposity and Anthropometric Measures………………………………………………19 
 CLAMS Measurements…………………………………………………………….......22 
Metabolic Efficiency……………………………………………………………...….....31 
 Glucose Tolerance Tests…………………………………………………………….….27 
 Western Blotting Analysis…………………………………………....…...……………..29  
Discussion……………………………………………………………………………………….31 
 Study Limitations………………………………………………………………………..42 
 Future Directions………………………………………………………………………..43 
References……………………………………………………………………………………...45 
Appendix A…………………………………………………………………………….………59 
Appendix B……………………………………………………………………………………..62 
Appendix C…………………………………………………………………………………...…63 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
List of Tables 
Table 1. CLAMS Measurements of Wild type (WT), mdx mice (mdx), and mdx/Sln-null mice 
(mdx SLNKO) Pre and Post Chow/HFD……………………………………………………..23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
List of Figures 
Figure 1. Experimental Diet Design; HFD: High Fat Diet; WT:  wild type; mdx: murinic model 
of Duchenne muscular dystropohy……………………………………………………………..14 
Figure 2. Greater change in mass in WT with no differences in final bodyweight at 
sacrifice…………………………………………………………………………………………..18 
Figure 3. Total Food Consumption across an 8 week high fat diet (HFD) for wild-type (WT), 
mdx, and mdx/Sln-null mice……………………………………………………………………18 
Figure 4. Fat pad mass, brown adipose tissue (BAT) weight, and adiposity index for chow fed 
control and HFD, wild type (WT), DMD mice (mdx), DMD Sln-null (mdx SLNKO) mice….20 
Figure 5. Soleus and liver weights for chow fed control and HFD, wild type (WT), mdx, and 
mdx/Sln-null (mdx SLNKO) mice……………………………………………………………..21 
Figure 6. Metabolic efficiency (M.E) pre and post HFD …………………………………….26 
Figure 7. Glucose tolerance curves and area under the curve (AUC) pre and post 8-week HFD 
…………………………….……………………………………………………………………...28 
Figure 8. SLN expression in diaphragm (DIA)……………………………………………….30 
Figure 9. UCP-1 expression in brown adipose tissue (BAT)…………………………………30 
 
 
 
 
 
 
 
 
 
 
1 
 
Introduction 
Calcium Regulation and Thermogenesis 
Calcium ions play a vital role in the physiology of living organisms. With respect to 
skeletal muscle, calcium regulates excitation-contraction coupling (ECC) (Stammers et al., 
2015), apoptosis (Berchtold et al., 2000), secondary messenger signaling (Gailly, 2002), and 
energy expenditure (Bombardier et al., 2013a; Bombardier et al., 2013b). The precise regulation 
of intracellular free calcium ([Ca2+]f) is essential for proper skeletal muscle function and health. 
The sarcoplasmic reticulum (SR) is the primary organelle responsible for the dynamic control of 
both cytoplasmic and SR calcium levels in striated muscle (Martonosi and Pikula, 2003). The SR 
maintains a resting [Ca2+]f within a concentration of 20-60 nM while maintaining a relatively 
greater luminal concentration creating a large Ca2+  gradient (1:10, 000) across the SR membrane 
(Schiaffino & Reggiani, 2011). 
One of the integral SR membrane proteins that contributes to SR [Ca2+]f regulation is the 
sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) pump. SERCAs are a 110kDa membrane 
proteins responsible for the transport of calcium and the maintenance of [Ca2+]f (MacLennan, 
Asahi, and Tupling, 2003). SERCA is a member of the protein family known as P-type ATPases, 
which utilize the energy from ATP to act as cation transporters (Toyoshima et al., 2000). The 
structural organization of SERCA is divided into three domains, a cytoplasmic head region, a 
transmembrane region containing the calcium binding sites, and luminal loops (Toyoshima et al., 
2000; Toyoshima & Inesi, 2004; Stammers et al., 2015). The transmembrane region is comprised 
of 10 transmembrane domains (M1-M10) and the cytoplasmic head region is characterized by 
three cytoplasmic domains: the actuator domain, nucleotide binding domain, and the 
phosphorylation domain (Toyoshima et al., 2000). Although Ca2+: ATP stoichiometry can be 
variable, the two calcium binding sites and one ATP binding site on SERCA corresponds to an 
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optimal coupling ratio of 2 Ca2+ for 1ATP hydrolyzed (Toyoshima, 2007). The two major 
conformational states of SERCA are the E1 and E2 states. Assuming an optimal ratio of 2 Ca2+ 
for 1 ATP hydrolyzed, the reaction cycle for SERCA mediated Ca2+ transport would proceed 
with 2 Ca2+ binding to the two Ca2+ binding sites on SERCA (Toyoshima & Inesi, 2004). The 
two major conformational states of SERCA are the E1 and E2 states. During the E1 state, the 
Ca2+ binding sites (M4, M5, M6, and M8 transmembrane proteins) have a high affinity for 
cytoplasmic calcium (Toyoshima, 2007). Once calcium ions are bound to SERCA in its E1 
conformation, SERCA undergoes autophosphorylation by ATP at Asp351 at its phosphorylation 
domain forming a high energy phosphoprotein intermediate (E1P) (Toyoshima, 2007). SERCA 
transitions from E1P to a low energy phosphoprotein intermediate known as E2P (Toyoshima, 
2007). The low energy state, E2P, is characterized by low SERCA calcium affinity, resulting in 
the release of calcium into the SR lumen (Toyoshima, 2007). Although Ca2+: ATP stoichiometry 
can be variable, the two calcium binding sites and one ATP binding site on SERCA corresponds 
to an optimal coupling ratio of 2 Ca2+ for 1 ATP hydrolyzed (Toyoshima, 2007). This optimal 
ratio can be influenced by changes in physiological conditions, whereby the coupling ratio can 
be altered. A reduction in SERCA coupling ratio can occur as result of alterations in ADP/ATP 
ratios, [Ca2+]f, and sarcolipin (SLN) (Smith et al., 2002; Mall et al., 2006; Reis, Farage, & de 
Meis, 2002). There are three sources of reduced SERCA coupling ratio. First is a process known 
as a passive leak or uncoupled Ca2+ efflux whereby high concentrations of luminal SR Ca2+ 
results in the passive efflux of Ca2+ from the lumen of the SR back into the muscle cytoplasm, 
this occurs due to the binding of Ca2+ to SERCA in its E2 state before it can revert to its E1 state 
(Berman, 2001; de Meis, 2001b). The second is known as uncoupled ATPase activity, where the 
forward conformational transition from E1-Ca2-P to E1-Ca2-P is slowed down due to the high 
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luminal concentrations of Ca2+, this increases the number of SERCA pumps in the E1-Ca2-P 
state resulting in the cleavage of Pi before Ca2+ is translocated to the SR lumen (Berman, 2001; 
de Meis, 2001b). Finally, in a process known as slippage where the Ca2+ ion is prematurely 
released back into the muscle cytoplasm instead of the SR lumen during the conformational 
transition from E1-Ca2+-P to E2-Ca2+-P. A decrease in SERCA Ca2+ affinity when it is in the E1-
Ca2+-P is believed to be the cause of slippage (Smith et al., 2002; Berman, 2001). This reduction 
in affinity can be the result of high luminal Ca2+ concentrations or an interaction with SERCA 
regulatory proteins such as SLN and phospholamban (PLN). Although the three modalities of 
reducing Ca2+: ATP stoichiometry are different, all three have the same result that most of the 
energy released from the hydrolysis of ATP is released as heat rather than the successful 
translocation of Ca2+ into the SR (Mall et al., 2006; Reis, Farage, and de Meis, 2002). This 
reduction in SERCA efficiency as a means to increase energy expenditure has been postulated as 
novel mechanism of skeletal muscle based adaptive thermogenesis. 
Adaptive Thermogenesis and Sarcolipin 
Adaptive thermogenesis refers to an increase in energy expenditure due to perturbations 
in either temperature or diet. It is important for a living organism to possess the ability to 
regulate energy expenditure during times of either food shortage or excess since it helps preserve 
energy stores and maintain body temperature. An inability to regulate either energy stores or 
body temperature can result in metabolic disorders such as obesity or even death. There are two 
mechanisms of adaptive thermogenesis: shivering thermogenesis and non-shivering 
thermogenesis.  
Shivering thermogenesis involves the contraction of skeletal muscles, which generate 
metabolic heat (Cannon & Nedergaard, 2004). Skeletal muscle contraction/relaxation is a 
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process that is energy dependent requiring ATP at the level of the myosin ATPase and SERCA, 
two of the major energy consuming complexes during contraction. A complex series of both 
electrical and mechanical steps are involved in a process known as excitation-contraction (EC) 
coupling, a term linking the depolarization of the sarcolemma to the release of intracellular 
calcium from the SR, resulting in the formation of actin-myosin cross-bridges, and force 
production (Dulhunty, 2006). The formation of cross-bridges between actin and myosin by 
myosin ATPase, and the eventual re-uptake of calcium by SERCA, consume ATP and generate 
heat. Skeletal muscle represents the most direct avenue in which to increase energy expenditure 
either to help maintain body temperature or through exercise activity, prevent obesity. However, 
the elevated metabolic rate persists despite cessation of shivering during prolonged cold 
exposure, which underlies the importance of other mechanisms of thermogenesis, specifically 
non-shivering thermogenesis. 
Non-shivering thermogenesis is the heat generated as result of mitochondrial proton leak 
seen in brown adipose tissue (BAT) (Cannon & Nedergaard, 2004). Mitochondrial proton leak 
occurs due to the presence of uncoupling protein 1 (UCP-1) which disrupts the proton (H+) 
gradient by allowing protons to leak back into the mitochondrial matrix from the intermembrane 
space (Cannon & Nedergaard, 2004). The disruption of the proton motive force results in the 
uncoupling of ATP production from the movement of H+ into the intermembrane space, as a 
result there is an increase in the break down and oxidation of carbon energy substrates (sugar, 
starch, protein, fat) in order to synthesize more reducing agents (NADH and FADH2) in an effort 
to restore the disrupted mitochondrial H+ gradient (Cannon & Nedergaard, 2004). Other isoforms 
of uncoupling proteins exist, UCP-2 is another uncoupling protein seen in BAT (Vidal-Puig et 
al., 1997), and UCP-3 a skeletal muscle-based isoform (Vidal-Puig et al., 2000) where all three 
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proteins share very similar sequence homologies (Feldmann, 2009). A study examining the 
effects of the ablation of UCP-1 in mice have found that at thermoneutrality (~30°C; a 
temperature at which no further compensatory thermogenesis mechanisms are needed to regulate 
body temperature), mice fed either a chow or a caloric dense high fat diet (HFD) are obese 
(Feldmann, 2009). The ability of UCP-1 to uncouple ATP production underlies an increase in 
energy expenditure which helps mitigate obesity pathogenesis. In a subsequent study, mice with 
overexpression of UCP-3 in their skeletal muscles were found to be protected from an obesity 
phenotype despite being fed a HFD (Son et al., 2004). These studies suggest that mice can be 
protected from obesity due to the existence of non-productive energy expending mechanisms. It 
has been suggested that other mechanisms may exist which help “waste energy” in an effort to 
attenuate excess caloric consumption and subsequent weight gain. One such mechanism may be 
SLN mediated slippage of Ca2+.  
SERCA function is regulated by several integral membrane proteins, including SLN 
(Asahi et al., 2003; Bal et al., 2012). SLN is a 31-amino acid protein, organized into three 
distinct domains, a cytoplasmic domain comprised of 7 hydrophilic amino acids, a hydrophobic 
19 amino acid transmembrane domain, and a 6 amino acid luminal domain (MacLennan, Asahi, 
& Tupling, 2003). The expression of SLN protein in rodent tissue has been found to be abundant 
in the atria, the soleus (SOL), and the diaphragm (Vangheluwe et al., 2005a). SLN physically 
interacts with SERCA at its transmembrane domains (M4, M5, M6, and M8) (Toyoshima et al., 
2000; Toyoshima & Inesi, 2004). The M4 and M6 transmembrane domains make up the calcium 
binding sites, whereby the physical presence of SLN can reduce SERCA calcium affinity and 
result in the premature release of calcium into the muscle cytoplasm instead of being translocated 
into the SR lumen during its catalytic cycle. Thus, SLN reduces the apparent affinity for Ca2+ in 
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both cardiac and skeletal muscle, as well as reducing maximal Ca2+ uptake activity (Toyoshima 
et al., 2000; Toyoshima & Inesi, 2004; Stammers et al., 2015). The uncoupling of ATP 
hydrolysis from SERCA Ca2+ uptake is another physiological role that SLN is responsible for. 
The amount of heat generated per molecule of ATP was increased as a result of SLN 
reconstitution in artificial membrane experiments (Smith et al., 2002). A greater rate of slippage 
may be the potential explanation for SLN ability to uncouple ATP hydrolysis from Ca2+ uptake. 
As mentioned in the first section, slippage occurs when Ca2+ ions are released prematurely while 
SERCA undergoes a conformational change between the E1 and E2 states. The unsuccessful 
translocation of Ca2+ from the muscle cytoplasm to the SR and the fact that ATP hydrolysis still 
occurs, results in reduced fraction of energy used to transport Ca2+ into the SR thereby reducing 
the coupling ratio (Ca2+ transported: ATP hydrolyzed) (Smith et al., 2002; Mall et al., 2006; de 
Meis, 2001a).  
The interaction between SLN and SERCA has been postulated as a novel mechanism of 
diet induced thermogenesis (DIT), a form of non-shivering thermogenesis in response to 
excessive calorie consumption.  In the soleus (SOL) of SLN ablated (Sln-null) mice, the apparent 
coupling ratios are higher than in WT counterparts (Bombardier et al., 2003b). A higher coupling 
ratio signifies a more energetically efficient transport of Ca2+ into the SR lumen, since Sln-null 
mice are able to transport a given amount of Ca2+ into the SR lumen at a lower energy cost. 
However, greater efficiency of Ca2+ transport can predispose Sln-null mice to obesity when fed 
an 8 week HFD (Bombardier et al., 2003b). This has been attributed to the absence of SLN 
mediated skeletal muscle adaptive thermogenesis and is characterized by greater weight gain, 
greater adiposity, and poorer glucose tolerance (Bal et al., 2012). In WT mice, a 3-5 fold increase 
in SLN is also observed in response to high fat feeding, further suggesting that SLN upregulation 
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is a mechanism of preventing excessive weight gain by promoting a decrease in SERCA energy 
efficiency (Bal et al., 2012; Bombardier et al., 2003a). The upregulation of SLN can also be 
observed in skeletal muscle disease states, such as Duchenne muscular dystrophy (Schneider et 
al., 2013). 
Duchene Muscular Dystrophy and Sarcolipin 
Duchenne muscular dystrophy (DMD) is an X-linked disease caused by a frame shift 
mutation in the dystrophin gene, abolishing the production of functional dystrophin protein 
(Blake et al., 2002; Bulfield et al., 1984; Dupont-Versteegden et al., 1994; Schneider et al, 2013; 
Sicinski et al., 1989). Dystrophin is a 427 kDa cytoplasmic protein that plays a key role in 
assembling several cytosolic and transmembrane proteins into the dystrophin associated 
glycoprotein complex (Blake et al., 2002; Bonilla et al., 1988; Garcia-Pelagio et al., 2011). 
Although the precise function of dystrophin remains unknown, its role in muscle function has 
been explored by its absence in animal models.  
mdx mice (C57/BL10 background), the murine model of DMD, are genetically similar to 
DMD, with a nonsense point mutation centered on exon 23 of the dystrophin gene leading to an 
absence of dystrophin protein (Bonilla et al., 1988; Bulfield et al., 1984; Turner et al., 1988), and 
is a common model used to understand the DMD pathology (Bulfield et al., 1984; Turner et al., 
1988). mdx mice display progressive diaphragm degeneration and cycles of skeletal muscle 
degeneration and regeneration analogous to DMD (Bonilla et al., 1988, Schneider et al., 2013; 
Turner et al., 1998; Willmann et al., 2009). The lack of dystrophin has been associated with 
membrane fragility as indicated by the high concentration of endogenous extracellular proteins 
albumin, IgG, and IgM, in the muscle cells (McGreevy et al., 2015; Mokhtarian et al., 1996). 
This has been attributed to the inability of cytoskeletal γ-actin to bind to the sarcolemma, leaving 
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the muscle vulnerable to mechanical stress and muscle damage (Dupont-Versteegden et al., 
1994; Garcia-Pelagio et al., 2011; McGreevy et al., 2015). An absence of dystrophin has also 
been linked to membrane fragility which is associated with aberrant calcium handling and 
persistent increases in [Ca2+]f  (Culligan et al., 2002; McGreevy et al., 2015; Turner et al., 1988; 
Woods et al., 2004).  
The increased influx of Ca2+ is initially started by mechanosensitive cation channels or 
stretch activated channels, preceding any signs of muscle damage and degeneration in young 
mdx mice, and is believed to be the primary source of Ca2+ entry into dystrophic muscle (Franco-
Obregon Jr & Lansman, 1994). During subsequent contractile activity, transient membrane tears 
can occur which allow for localized influxes of calcium, a subsequent exocytotic transport of 
Ca2+ leak channels to the sarcolemma occurs which exacerbates the increased [Ca2+]f  (Turner et 
al., 1991). High [Ca2+]f in skeletal muscle have been associated with degeneration and necrosis 
in mdx mice muscle (Gailly, 2002; Whitehead et al., 2006). Ca2+-activated proteases, most 
notably calpains are responsible for promoting the degradation of numerous proteins which 
include membrane and cytoskeletal proteins. Calpain activity is higher in mdx mice than in WT 
mice, and remains elevated during periods of regeneration and degeneration (Spencer et al., 
1995).  The high [Ca2+]f is also responsible for increased reactive oxygen species (ROS) 
production due to mitochondrial Ca2+ overload which impairs oxidative phosphorylation and 
normal mitochondrial Ca2+ handling (Kuznetsov, et al., 1998). 
With respect to treatment, DMD at present has no known cure, however several treatment 
options have been explored. Genetic treatments include gene therapy aimed at either expressing a 
truncated, yet still in frame, dystrophin gene or restoring the dystrophin in its entirety (McGreevy 
et al., 2015). The goal of such therapy is to restore a functional gene or repair the gene through 
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targeted correction to restore dystrophin in DMD subjects (McGreevy et al., 2015). 
Pharmaceutical treatments have primarily focussed on glucocorticoids which help mitigate DMD 
pathology by reducing the breakdown of protein and increasing muscle mass (McGreevy et al., 
2015). Another potential target of treatment has been the aforementioned calcium dysregulation 
observed in mdx mice.  A recent study examining the downregulation of SLN in mdx utrophin 
knockout (utr -/-) mice, a more severe form of muscular dystrophy that mimics human DMD, 
saw reduced pathophysiology and improved muscle function (Voit, 2017). One of the major 
characteristics of mdx mice is their high energy expenditure and inability to meet that energy 
demand, possibly due to cycles of skeletal muscle degeneration and regeneration (Radley et al., 
2014). As a result, dietary interventions have been explored in addition to pharmaceutical and 
genetic treatment options. Potential dietary interventions aimed specifically at protein/amino acid 
supplementation have been examined extensively (Radley et al., 2007). However, their benefits 
remain mixed as some studies have shown potential benefits while others have shown no 
improvement (for review see Radley et al., 2007). Due to the high energy demand of mdx mice, 
interventions using a caloric dense HFD have been explored as a therapeutic option (Radley-
Crabb et al., 2011).  
High fat feeding and mdx mice 
Previous work has shown that mdx mice are in a constant state of caloric deficit, where 
their energy intake is unable to meet their energy demands (Radley-Crabb et al., 2011; Radley-
Crabb et al., 2014). This calorie deficit has been postulated as an exacerbating complication of 
the mdx disease, as muscles and protein must be broken down and used as energy substrates to 
meet mdx energy demands. As a result, Radley-Crabb (2011) fed mdx mice a calorie rich HFD 
(32% kcal from fat) in an effort to compensate for high energy expenditure to mitigate the 
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severity of mdx mice dystropathology (Radley-Crabb et al., 2011). After 24 weeks, the 
bodyweights of the mdx mice did not significantly change after consuming a HFD, whereas WT 
mice had significantly higher body weights (Radley-Crabb et al., 2011). The differences in 
bodyweight between mdx and WT mice could not be accounted for by differences in food 
consumption or by differences in the amount of activity (Radley-Crabb et al., 2011). The body 
composition comparisons between the two strains revealed that the mdx mice also had 
significantly smaller fat pad masses in contrast to WT. High fat feeding also had a profound 
impact on the dystropathology of mdx mice improving muscle fibre integrity (Radley-Crabb et 
al., 2011). It should be noted that the diet used in the study was not using a Westernized high fat 
diet. Although, the diet (32% kcal from fat) is relatively higher in fat in comparison to the chow 
diet given (5% from fat; 22/5 Rodent Diet (w) 8640; Harlan Teklad, Madison WI), it is 
considerably lower than the Westernized high fat diet (42% kcal from fat; product TD 88137; 
Harlan Teklad, Madison, WI) used in previous studies (Bombardier, 2010; Gamu, 2012). Pilot 
work has shown that mdx mice fed a Westernized HFD are still protected from obesity. Even 
with the higher percentage HFD, mdx mice had lower weight gain in comparison to WT mice, 
had lower adiposity, and displayed lower metabolic efficiency. Potential mechanisms of higher 
energy expenditure in mdx mice have often focussed on the cycles of degeneration and 
regeneration and protein synthesis (Dupont-Versteegden et al., 1994; Mokhatrian et al., 1996; 
Radley et al., 2007; Radley-Crabb et al., 2014). However, protection against obesity as a possible 
consequence of SLN upregulation in mdx mice has not been explored, despite SLN’s established 
role in adaptive thermogenesis. 
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Statement of the Problem 
The increase in SLN and protection from diet-induced obesity in mice has lead us to 
believe that SLN may be a major protective mechanism against diet-induced obesity in mdx 
mice. To investigate the potential protective role of SLN against obesity in mdx mice, a 
transgenic line of mdx/Sln-null mice were examined and compared with mdx and WT mice.  
Research Objectives: 
General Objective: 
• Determine if SLN mediated diet induced thermogenesis is a major mechanism of obesity 
protection in mdx mice. 
Specific Objectives: 
i) To compare relative sarcolipin levels in mdx and WT mice after HFD. 
ii) To determine if mdx/Sln-null mice are protected against obesity. 
iii) To determine if differences in VO2, activity Levels, and food Consumption have any 
effect on obesity protection in mdx mice. 
Hypotheses: 
i) SLN levels in mdx mice will be higher in comparison to WT mice. Since HFD increases 
the expression of SLN, SLN will increase in both strains, but the SLN levels will be 
higher in mdx mice due to its already high expression in skeletal muscle. 
ii) In comparison to WT mice, mdx mice will be protected from obesity after consuming a 
Western high fat diet, which will be denoted by lower body weight, lower adiposity, and 
lower blood glucose measures. 
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iii) mdx/Sln-null mice will not be as obese as WT, but will not be protected from obesity 
after consuming a Western high fat diet with a higher body weight, higher adiposity, and 
higher blood glucose measures in comparison to mdx mice. 
iv) Energy expenditure in mdx mice will be higher in response to the elevated levels of 
sarcolipin and thermogenesis as a result of high fat feeding, with no significant 
differences in activity levels. 
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Methods 
Experimental Animals 
mdx mice were purchased from Jackson Laboratories with intention of breeding an mdx 
SLN and mdx/Sln-null colony. The mdx mice were crossed with a Sln-null colony maintained at 
the University of Waterloo in order to create a line of mdx/Sln-null mice. Animals for the 
proposed project were hemizygous mdx males and WT littermates. A wild type comparison was 
considered a necessary group in order to observe the degree of protection from obesity in mdx 
mice and mdx/Sln-null mice. For the duration of the study, animals were individually housed in 
an environmentally controlled room on a regular 12:12 light dark cycle and allowed access to 
food and water ad libitum. Analyses were conducted on soleus and diaphragm, since SLN are 
normally observed in these tissues. All experiments were reviewed and approved by the 
University of Waterloo Animal Care Committee in accordance with the Canadian Council on 
Animal Care. 
Experimental Design 
WT, mdx, and mdx/Sln-null were randomly assigned to dietary treatments as outlined 
below (Figure 1). The experimental diets were administered for a period of 8 weeks and 
comprised of ad libitum access to water and HFD (42% of kcal from fat, product TD 88137; 
Harlan Teklad, Madison, WI). Body mass was measured on a weekly basis during the 
administration of the experimental diets. The experimental design included 8-week chow fed 
control animals, whose data is included in Appendix A. 
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Whole-Body Metabolic Rate Measures 
WT, mdx, and mdx/Sln-null littermates were acclimated in clear plastic cages for one 
week and given ad libitum access to water and rodent chow (22/5 Rodent Diet (w) 8640; Harlan 
Teklad, Madison WI), prior to commencing whole-body metabolic measurements. Whole-body 
metabolic measurements were made using a Comprehensive Laboratory Animal Monitoring 
System (CLAMS; Oxymax Series; Columbus Instruments, Columbus OH). Animals were 
housed individually in clear plexiglass cages (20 cm x 10 xm x 12.5 cm) in a room that was 
temperature controlled to (~22° Celsius), on a reverse light dark cycle and allowed access to 
water and powdered food (as above) ad libitum. Twenty-four hours were allocated to acclimate 
the mice to the CLAMS before commencing measurements and data collection for a period of 24 
hours thereafter. CLAMS measurements were completed two times during the same week, these 
measurements will be taken both before and after the experimental diets. Those mice who were 
allocated to the HFD will be given powdered high-fat food while in the CLAMS instead of the 
standard chow diet. The percent O2 and CO2 gas levels of the cages (20 cm x 10 cm x 12.5 cm) 
were measured periodically between reference readings of room air and were used to compute 
Figure 1. Experimental Diet Design; Pre: pre-HFD; Post: post-HFD; WT:  wild type; 
mdx: murinic model of Duchenne muscular dystrophy. 
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the O2 consumption (VO2) of the animal and used to calculate the daily metabolic rate. Relative 
VO2 measurements will be recorded in ml O2/kg/hr, whereas absolute VO2 will factor in the 
body weights of the animals and be recorded as ml O2/hr. In addition to metabolic rate, the 
CLAMs are equipped with a scale for monitoring mass of food consumed over time. There were 
also X and Z activity sensors for monitoring ambulatory activity (dual beam) counts (when 2 
adjacent X axis beams are broken in succession) in addition to both total activity and rearing 
activity. 
Whole-Body Glucose Tolerance Tests 
Pre- and post-diet Whole body glucose tolerance tests (GTT) were conducted on all mice 
as outlined in Gamu (2012). Mice were fasted overnight (16 hrs); following the fast, each mice 
was administered an intraperitoneal injection of 20% D-Glucose (1g/1kg body mass), a 5-10ul 
sample of venous blood was drawn from the tail vein and blood glucose measured using a 
glucometer (Contour Next; Bayer Diabetes Canada). Timepoints of blood glucose measure 
occurred immediately before intraperitoneal injection, after 30, 60, and 120 minutes post-
injection. 
Tissue Collection 
 Prior to commencing tissue collection, mice were placed on a four hour fast. 
Experimental animals were euthanized by cervical dislocation, the soleus and diaphragm were 
collected. All tissue samples were frozen in liquid N2 and stored at -80°C for future analyses. 
The retroperitoneal and epididymal fat pads were excised, cleaned of extraneous tissue and 
weighed. The weights of the epididymal, and retroperitoneal fat pads were used to calculate the 
adiposity index as: 
(Sum of epididymal and retroperitoneal pad masses/body mass) X 100 
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Western Blotting Analysis 
Soleus and diaphragm muscles from WT, mdx, and mdx/Sln-null mice were collected and 
homogenized 10:1 (volume/weight). Brown adipose tissue (BAT) was also collected and later 
homogenized 4:1 (volume/weight). Proteins will be separated in glycine based SDS-PAGE (13% 
Total AB6/AB3) for SLN. Separated proteins will be transferred onto a nitrocellulose membrane 
for SLN and a PVDF membrane for UCP-1 and immunoprobed with their corresponding primary 
antibodies and subsequently immunoprobed with the appropriate horseradish peroxidase-
conjugated secondary antibodies. Luminata ForteTM was used to detect SLN and UCP-1 antigen-
antibody complexes. Quantification of optical densities was determined using GeneTools 
(Syngene, MD, USA) and all values were normalized to whole protein content. 
Statistical Analyses 
One-way ANOVAs were used to test for differences between WT, mdx, and mdx/Sln-null 
groups with respect to changes in body weight post-HFD.  A two-way ANOVA, examining the 
factors of genotype and diet (pre/post-HFD), was used to detect differences in body weight, food 
consumption, all CLAMS measures, anthropometric measures such as fat pad masses, muscles 
and liver weights, as well as protein expression and glucose area under the curve (AUC) across 
all three genotypes, pre- and post-HFD.  Analyses were performed using Statistica 12 (Statsoft. 
Inc., Tulsa, OK, USA). Data are presented as means ± SE. The significance level was set at 0.05, 
and when appropriate, a Newman-Keuls post hoc test was used to compare specific means.  
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RESULTS 
Body Weight and Food Consumption 
Pre-diet body weight was higher (P < 0.0001) in mdx and mdx/Sln-null mice in 
comparison to WT mice with no differences observed between mdx groups (Fig.2b).  In response 
to the HFD, body weight of all three genotypes increased significantly (P < 0.0001), with WT 
gaining more mass versus both mdx and mdx/Sln-null at week 5 (P < 0.03), week 6 (P < 0.02), 
week 7 (P < 0.02), and week 8 (P < 0.01) of the HFD (Fig. 2a).  However, at the time of sacrifice 
(8 weeks Post-HFD), there were no differences in body weight between genotypes post-HFD 
(Fig.2b). Weight gain was also not different at any time point between high fat fed mdx and 
mdx/Sln-null mice (Fig. 2a). 
Total food consumption was measured across all 8 weeks of the HFD, and across all three 
genotypes. The total food consumption was significantly higher (P < 0.05) in mdx mice in 
comparison to WT and mdx/Sln-null mice (Figure 3). There was no difference (P = 0.99) in food 
consumption between WT and mdx/Sln-null mice. 
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Figure 2. Greater change in mass in WT with no differences in final bodyweight at 
sacrifice. A) Change in body mass of wild-type (WT), mdx, and mdx/Sln-null mice 
during 8 weeks of a high-fat diet (HFD). B) Pre- and Post-HFD bodyweights of WT, 
mdx, and mdx/Sln-null mice. Values are mean ± S.E. * Significantly different than 
corresponding mdx and mdx/Sln-null (P < 0.05). (WT: n = 9, mdx: n = 12, mdx/Sln-null; 
n = 8) 
Figure 3. Total Food Consumption across an 8 week high fat diet (HFD) for wild-type 
(WT), mdx, and mdx/Sln-null mice. *Significantly different from mdx mice. Values are 
mean ± S.E. * Significantly different than mdx (P < 0.05). (WT: n = 9, mdx: n = 12, 
mdx/Sln-null; n = 8) 
F
o
o
d
  
C
o
n
s
u
m
p
ti
o
n
 (
g
)
W T m dx m dx /S ln -n u l l
0
5 0
1 0 0
1 5 0
2 0 0
2 5 0
* *
W e e k s

  
M
a
s
s
 (
g
)
1 2 3 4 5 6 7 8
0
5
1 0
1 5
2 0
W T
m d x
m d x /S L N -n u l l
*
*
*
*
B
o
d
y
 W
e
ig
h
t
 (
g
)
P re -H F D P o s t-H F D
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
W T
m dx
m dx /S L N -n u l l
*
A B
18 
 
Adiposity and Anthropometric Measures 
 After consuming an 8-week high fat diet, an interaction (P < 0.02) was observed with 
mdx/Sln-null mice having higher epididymal fat pad masses, higher BAT fat pad masses, and a 
higher adiposity index compared to mdx mice post-HFD (Figure 4). An interaction close to 
statistical significance (P = 0.07) was observed with mdx/Sln-null mice having greater 
retroperitoneal fat pad masses in comparison to mdx mice post-HFD. Planned comparisons 
(Newman-Keuls) revealed that WT mice had greater epididymal fat pad masses (P < 0.001; 
Figure 4a), greater retroperitoneal fat masses (P < 0.001; Figure 4b), and higher adiposity index 
(P < 0.01; Figure 4d) than mdx/Sln-null and mdx mice regardless of diet. Post-HFD WT mice had 
greater (P < 0.001) BAT masses than post-HFD mdx/Sln-null and mdx mice, there were no 
differences between chow fed WT and mdx (P = 0.45) and mdx/Sln-null mice (P = 0.24).  A main 
effect of diet (P < 0.0001) was observed with fat pad masses and adiposity indexes being higher 
post-HFD compared to chow.  
When comparing soleus weights between groups, there were significant main effects of 
diet and genotype with soleus mass being heavier post-HFD compared with pre-HFD (P < 0.02) 
and in both mdx and mdx/Sln-null mice compared with WT (P< 0.0001; Figure 5a). The same 
main effects were observed when soleus weights were expressed as a percentage of bodyweight 
(Figure 5c). With respect to liver weights, an interaction (P < 0.05) was observed with WT mice 
having greater post-HFD liver weights than mdx and mdx/Sln-null mice, despite having the 
lowest liver mass pre-diet (Figure 5b). When liver weights were normalized to body weight, an 
interaction (P < 0.05) was observed with greater liver % BW post-HFD in WT mice and 
mdx/Sln-null mice in comparison to mdx mice, despite WT mice starting out with a low liver % 
BW and mdx/Sln-null mice having similar liver % BW pre-diet to mdx (Figure 5d). Planned 
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comparisons (Newman-Keuls) revealed that post-HFD mdx/Sln-null mice had significantly (P < 
0.05) higher liver % BW in comparison to post-HFD mdx mice, with no differences (P = 0.79) 
observed when compared to WT mice. Planned comparisons further revealed a significant 
increase in liver % BW post-HFD in WT mice in comparison to pre-HFD (P< 0.02). An 
interaction that was close to statistical significance (P= 0.08) was observed with greater liver % 
BW in HFD fed mdx/Sln-null mice in comparison to chow controls. No differences were 
observed between HFD and chow fed mdx mice (P= 0.93). 
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Figure 4. Fat pad mass, brown adipose tissue (BAT) weight, and adiposity index for chow fed control and HFD, wild type (WT), mdx mice, 
mdx/Sln-null mice. (A) epididymal fat pad mass; (B) retroperitoneal fat pad mass; (C) BAT mass; (D) adiposity index. All showed a main effect 
(P< 0.0001) of diet with HFD > Chow and main effect (P< 0.0001) of genotype with WT > mdx SLNKO > mdx. *Significantly different (P< 0.05) 
than mdx. #Significantly different from mdx/Sln-null. Values are means±SE (N=11 for WT Pre-HFD, N=9 for WT Post-HFD, N=13 for mdx Pre-
Chow, N=12 for mdx Post-HFD, N=8 for mdx mdx/Sln-null Pre-HFD, N=8 for mdx/Sln-null Post-HFD). 
E
p
id
y
d
m
a
l 
F
a
t 
P
a
d
 (
m
g
)
P re -H F D P o s t-H F D
0
5 0 0
1 0 0 0
1 5 0 0
W T
m d x
m d x /S LN -n u ll
*  #
*
R
e
tr
o
p
e
ri
to
n
e
a
l
F
a
t 
P
a
d
 (
m
g
)
P re -H F D P o s t-H F D
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
W T
m d x
m d x /S ln -n u ll
P = 0 .0 7
*  #
B
ro
w
n
 A
d
ip
o
s
e
T
is
s
u
e
 (
m
g
)
P re -H F D P o s t-H F D
0
1 0 0
2 0 0
3 0 0
W T
m d x
m d x /S ln -n u ll
*  #
*
A
d
ip
o
s
it
y
 I
n
d
e
x
P re -H F D P o s t-H F D
0
2
4
6
8
W T
m d x
m d x /S ln -n u ll *
*  #
A B
C D
*
21 
 
  
Figure 5. Soleus and liver weights for chow fed control and HFD, wild type (WT), mdx, and mdx/Sln-null mice. (A) Soleus mass (main effect of genotype: P 
< 0.0001 mdx/ mdx/Sln-null > WT; main effect of diet: P < 0.02, HFD > Chow); (B) liver weight (main effect of diet: P < 0.0001, HFD > Chow); (C) soleus 
% BW (main effect of genotype: P < 0.004, mdx/ mdx/Sln-null > WT; main effect of diet: P < 0.05); (D) liver % BW (main effect of diet: P<0.01, HFD > 
Chow). * Significantly different from mdx (P < 0.05). #Significantly different (P < 0.05) than mdx/Sln-null mice. Values are means±SE (N=11 for WT 
Pre-HFD, N=9 for WT Post-HFD, N=13 for mdx Pre-Chow, N=12 for mdx Post-HFD, N=8 for mdx mdx/Sln-null Pre-HFD, N=8 for mdx/Sln-
null Post-HFD). 
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CLAMS Measurements 
CLAMS data are presented in Table 1. Pre-HFD relative total daily VO2, relative waking 
VO2 and relative sleeping VO2, were significantly lower in mdx/Sln-null mice compared to both 
WT (P< 0.01) and mdx (P< 0.02) mice.  No differences (P > 0.5) in these pre-HFD relative VO2 
measures were observed between mdx and WT mice. However, for all pre-HFD absolute (ml 
O2/hr) VO2 measures (i.e. total, waking and sleeping), values were lower in WT mice compared 
with both mdx (P < 0.0001) and mdx/Sln-null (P < 0.01) mice.  No differences (P > 0.1) in these 
pre-HFD absolute VO2 measures were observed between mdx and mdx/Sln-null mice.  Planned 
comparisons revealed that mdx mice had 4% greater pre-HFD absolute daily VO2 compared to 
mdx/Sln-null mice, but the difference was not significant (P = 0.26).  Pre-HFD total and dual 
cage activity were higher (P < 0.001) in WT mice in comparison to mdx and mdx/Sln-null mice.  
Both pre-diet total and dual beam activity were not different (P > 0.05) in mdx versus mdx/Sln-
null mice. 
Following the 8-week HFD, relative total daily, waking and sleeping VO2 were higher (P 
< 0.05) in mdx mice in comparison to both WT and mdx/Sln-null mice.  Furthermore, post-HFD 
relative total daily, waking and sleeping VO2 were higher in WT compared to mdx/Sln-null mice.  
A main effect of diet (P < 0.0001) was also observed with all three animal groups having lower 
relative total daily, waking and sleeping VO2 post-HFD compared with pre-HFD.  In contrast to 
relative VO2, all absolute VO2 values were higher (P < 0.05) post-HFD in comparison to pre-
HFD.  Similar to relative VO2, all absolute VO2 values were higher (P< 0.0001) in mdx mice in 
comparison to WT and mdx/Sln-null mice, with the exception of absolute sleeping VO2, which 
was not different (P = 0.24) between mdx and mdx/Sln-null mice.  Food intake (g) also 
demonstrated a main effect (P < 0.0001) of diet with post-HFD intake being lower than pre-
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HFD.  No significant differences were found in food consumption between the three groups 
either pre- or post-HFD.  The smaller quantity (g) of high fat food eaten by all three groups of 
mice was calculated to have the same amount of metabolizable energy as the standard rodent 
chow eaten during pre-HFD CLAMS measurements (3.0 kcal/g for standard chow versus 4.5 
kcal/g for the HFD; Table 1).  For activity levels there was a main effect (P < 0.01) of genotype, 
whereby WT mice had greater total activity and dual beam activity than both mdx and mdx/Sln-
null mice both pre- and post-HFD.  There was no main effect of diet for either total activity (P = 
0.67) or dual beam activity (P = 0.79). Finally, a main effect of diet (P < 0.0001) was found for 
all three-respiratory exchange ratio (RER) values with pre-HFD values being higher than post-
HFD values.  There was also a main effect of genotype (P < 0.05) for sleeping RER, with WT 
mice having higher values than both mdx and mdx/Sln-null mice.
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Table 1.  CLAMS Measurements of Wild type (WT), mdx, and mdx/Sln-null mice Pre and Post-HFD  
 
 Pre Post 
 WT mdx mdx/Sln-null WT mdx mdx/Sln-null 
 
Body Weight 
(g) 
 
 
30.6 ± 1.3 
 
 
34.5 ± 1.1# 
 
 
34.8 ± 0.77# 
 
 
44.6 ± 2.4* 
 
 
44.3 ± 1.7* 
 
 
45.3 ± 1.1* 
 
 
Waking VO2 
(ml O2/kg/hr) 
 
 
3457± 55 
 
3461 ± 55 
 
3250 ± 59#$ 
 
2909 ± 52* 
 
3349 ± 113*# 
 
2805 ± 42*#$ 
 
Sleeping VO2 
(ml O2/kg/hr) 
 
 
2668 ± 80 
 
2781 ± 68 
 
2630 ± 26#$ 
 
2587± 62* 
 
2733 ± 59*# 
 
2456 ± 46#$ 
 
Total Daily 
VO2 (ml 
O2/kg/hr) 
 
 
 
3203 ± 51 
 
 
3240 ± 55 
 
 
3038 ± 70#$ 
 
 
2838 ± 52* 
 
 
3135 ± 76*# 
 
 
2689 ± 37*#$ 
 
Food Intake 
(g) 
 
 
3.83 ± 0.31 
 
3.97 ± 0.22 
 
4.20 ± 0.25 
 
2.47 ± 0.19* 
 
2.57 ± 0.24* 
 
2.57 ± 0.31* 
 
Metabolizable 
Energy (kcal) 
 
 
11.49 ± 0.93 
 
11.9 ± 0.66 
 
12.61 ± 0.76 
 
 
11.13 ± 0.19* 
 
11.55 ± 0.52* 
 
11.56 ± 0.49* 
 
Total Activity 
 
 
10776 ± 718 
 
7624 ± 215# 
 
7072 ± 174# 
 
9852 ± 450 
 
8257 ± 209# 
 
7750 ± 132# 
 
Dual Beam 
Activity 
 
 
3632 ± 349 
 
 
2601 ± 238# 
 
2515 ± 198# 
 
3358 ± 198 
 
2728 ± 134# 
 
2471 ± 128# 
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Waking VO2 
(ml O2/hr) 
 
103 ± 4.7 
 
119 ± 2.8# 
 
113 ± 1.2# 
 
116 ± 6.3* 
 
140 ± 5.1*# 
 
126 ± 2.7*#$ 
 
Sleeping VO2 
(ml O2/hr) 
 
 
79 ± 3.8 
 
95 ± 2.0# 
 
91 ± 1.2# 
 
104 ± 6.4* 
 
119 ± 5.1*# 
 
111 ± 3.5* 
 
Daily VO2 
(ml O2/hr) 
 
 
95 ± 4.1 
 
111 ± 2.3# 
 
105 ± 1.4# 
 
116 ± 5.8* 
 
137 ± 4.7*# 
 
118 ± 5.4*$ 
 
Awake RER 
 
 
0.921 ± 0.007 
 
0.920 ± 0.009 
 
0.916 ± 0.014 
 
0.815 ± 0.007* 
 
0.806 ± 0.007* 
 
0.794 ± 0.011* 
 
Sleep RER 
 
 
0.908 ± 0.009 
 
0.891 ± 0.007 
 
0.8907 ± 0.005 
 
0.798 ± 0.009* 
 
0.774 ± 0.009* 
 
0.768 ± 0.013* 
 
Total RER 
 
0.912 ± 0.010 
 
0.906 ± 0.009 
 
0.906 ± 0.01 
 
0.807 ± 0.008* 
 
0.794 ± 0.009* 
 
0.784 ± 0.01* 
 
       
Main effect of diet (Pre < Post) for Body Weight (P<.0001). Main effect of diet (Pre > Post) Waking, Sleeping, and Daily VO2 (P<0.0001), Food 
Intake (P<0.0001), Total Activity (P<0.05), Dual Beam Activity (P<0.05), and Waking, Sleeping, Total RER (P<0.0001). Main effect of genotype 
(WT>mdx and mdx/Sln-null) for sleeping RER (P<0.05).*Significantly different from Pre (P<0.05). #Significantly different from WT. $ 
Significantly different than mdx. VO2, oxygen consumption, RER, respiratory exchange ratio. Values are Mean ± SEM (N=9 for WT, N=12 for 
mdx, N=8 for mdx SLNKO) 
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Metabolic Efficiency 
Metabolic efficiency (M.E) was calculated by dividing the change in body weight by the 
amount of energy derived from either chow or high fat diet converted to kJ. An interaction (P < 
0.0001) was found, with WT mice having significantly greater metabolic efficiency post-HFD 
than mdx and mdx/Sln-null mice (Figure 6). Planned comparisons revealed a trend (P = 0.07) 
towards higher metabolic efficiency in mdx/Sln-null mice in comparison to mdx mice post-HFD 
(Figure 8).  There were no differences in metabolic efficiency pre-HFD. 
  
 
 
 
 
 
 
 
 
Figure 6. Metabolic efficiency (M.E) pre- and post- HFD. M.E. increases in response to high 
fat diet (main effect of diet: P < 0.0001). Trend towards higher metabolic efficiency in 
mdx/Sln-null vs mdx mice (P=0.07). *Significantly greater than mdx mice (P < 0.0001). # 
Significantly greater than mdx/Sln-null mice (P < 0.0001). Values are mean ± S.E. (N=8 for 
WT, N=12 for mdx, N=8 for mdx SLNKO) 
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Glucose tolerance tests 
GTT were performed on WT, mdx, and mdx/Sln-null mice pre- and post-HFD (Figure 
5a). There were large differences between pre- and post-HFD responses with the glucose values 
being lower (P < 0.001) at all time points during pre-diet tests compared with post-diet tests in 
WT (Fig. 7a) and at two time points in mdx/Sln-null mice (Fig. 7b). There were no differences 
observed between pre- and post-diet responses with mdx mice (Fig. 7a). A trend towards an 
interaction (P = 0.06) was observed showing greater glucose intolerance (higher blood glucose 
levels) post-HFD in mdx/Sln-null mice compared with WT (Fig. 7b) and mdx mice (Fig. 7c). 
Planned comparisons (Neuman-Keuls) between mdx and mdx/Sln-null at the 60 and 120 min 
time points showed that mdx/Sln-null were more (P < 0.05) glucose intolerant post-HFD in 
comparison to mdx mice. A comparison of pre-diet values revealed no significant differences 
between mdx and mdx/Sln-null mice.   
Whole glucose excursions after an intraperitoneal injection of glucose are a good 
representation of glucose tolerance. Another index of glucose tolerance is the glucose area under 
the curve (AUC), which represents the total amount of blood glucose throughout the two-hour 
glucose tolerance test, where greater values will represent poorer glucose tolerance. When 
expressed as an AUC, an interaction was observed (P< 0.02) with mdx/Sln-null mice showing 
greater blood glucose post-HFD in comparison to mdx and WT mice (Fig. 7d). Planned 
comparisons (Neuman-Keuls) showed that post-HFD blood glucose levels were greater (P < 
0.05) in mdx/Sln-null mice in comparison to mdx mice; WT mice tended (P = 0.08) to have lower 
AUC values post-HFD in comparison to mdx/Sln-null mice.
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Figure 7. Glucose tolerance curves and area under the curve (AUC) pre and post 8-week HFD. (A) Wild type (WT) vs. mdx, (B) WT vs. mdx/Sln-null, (C) 
mdx vs mdx/Sln-null, (D) Glucose AUC. Main effect of genotype (P < 0.0001), WT < mdx/ mdx/Sln-null. Main effect of time (P < 0.0001), 0 < 120 < 30 
< 60. *Significantly different from Pre (P < 0.05). # Significantly different from WT (P < 0.05). $ Significantly different from mdx (P < 0.05). Values are 
Mean ± SEM (N=11 for WT, N=12 for mdx, N=8 for mdx/Sln-null) 
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Western Blotting Analysis 
 Comparisons between chow fed WT, mdx mice, and mdx/Sln-null revealed that SLN is 
elevated in the mdx diaphragm (P < 0.0001) by a factor of 2, SLN was not detected in the 
mdx/Sln-null samples (Figure 8). Due to “technical issues”, SLN expression could not be 
accurately detected in the soleus. Comparisons between HFD fed WT and mdx mice shows that 
SLN remains elevated in the mdx diaphragm (P < 0.02) by a factor of 1.5. Interestingly, SLN 
levels decreased (P < 0.05) in the diaphragms of mdx mice post-HFD. UCP-1 was elevated (P < 
0.02; Figure 9) post-HFD across all three genotypes, WT (30%), mdx (29%), and mdx/Sln-null 
(25%). However, UCP-1 content was not different (P > 0.05; Figure 9) between WT, mdx, and 
mdx/Sln-null post-HFD.  
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Figure 9. UCP-1 expression in brown adipose tissue (BAT). Post-HFD, UCP-1 expression increased 
in WT (30%), mdx (29%), and mdx/Sln-null (25%). No significant differences between all three 
genotypes. *Significantly different from Chow (P < 0.05). Values are mean ± S.E (N=8 for WT Pre-
HFD, N =8 for WT Post-HFD, N=8 for mdx Pre-HFD, N=8 for mdx Post-HFD, N=8 for mdx/Sln-null 
Pre-HFD, N=8 for mdx/Sln-null Post-HFD). 
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Figure 8. SLN expression in diaphragm (DIA). SLN is higher in mdx diaphragm by a factor of 2. 
Post-HFD the SLN expression remained higher in mdx diaphragm in comparison to WT mice by 
factor of 1.75. *Significantly different than WT (P < 0.05). Values are mean ± S.E (N=9 for WT Pre-
HFD, N=8 for WT Post-HFD, N=9 for mdx Pre-HFD, N=9 for mdx Post-HFD). 
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Discussion 
 This study set out to assess the role of SLN in providing protection against high fat diet 
induced obesity in mdx mice. The main findings of this study were: 1) SLN content in the 
diaphragm was higher in mdx mice compared to WT mice; 2) mdx/Sln-null mice had statistically 
significantly greater adiposity post-HFD, despite a non-statistical significant increase in body 
weight in comparison to mdx mice; 3) in accordance with the ablation of SLN, mdx/Sln-null 
mice demonstrated a lower whole body metabolic rate in comparison to mdx mice. Altogether 
these results further support SLN’s thermogenic role, wherein the absence of SLN is a major 
mechanism of diet induced obesity in mdx/Sln-null mice.  
 A previous study saw an upregulation of SLN in the diaphragm and soleus of mdx mice 
(Schneider et al., 2013). As hypothesized, there was a significant difference in the expression of 
SLN between WT and mdx mice, with a 2-fold higher expression in the diaphragm of mdx mice 
vs WT mice (Fig. 8). In relation to the Schneider study, a similar difference was observed with 
mdx diaphragm expressing a 3-fold increase in comparison to WT mice (Schneider et al., 2013). 
Schneider et al. (2013) also observed a 10-fold difference in the expression of SLN in the soleus 
muscle of mdx mice in comparison to WT mice. This finding could not be corroborated during 
this study due to the lack of viable results that could be systematically discerned due to technical 
issues. However, the finding of higher expressions of SLN in the diaphragm of mdx mice helps 
corroborate the finding that SLN is upregulated in mdx mice.  
A novel finding was that after consuming a high fat diet, SLN in the diaphragm declined 
in mdx mice by 30% (Fig. 8). This decrease in SLN expression may seem paradoxical as SLN 
has been found to increase in soleus muscles of high fat fed animals (Bombardier, 2010). 
However, the thermogenic contribution of diaphragm to skeletal muscle non-shivering 
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thermogenesis is at this time unknown and the expression of SLN in diaphragm post-HFD has 
not been shown to change (Bal et al., 2012). This was corroborated in this study as SLN 
expression in the diaphragm of WT mice did not change after an 8-week HFD (Fig. 8). The 
upregulation in SLN seen in the muscles of mdx has been proposed as a contributing factor to it’s 
pathology (Schneider et al., 2013). However, SLN upregulation has also been proposed as a 
compensatory mechanism to combat mdx pathology by upregulating utrophin, a dystrophin 
homologue, through increased NFAT translocation to the muscle nucleus via calcineurin 
activation (Fajardo, 2015). A previous study examining the quadriceps of mdx mice post-HFD 
have found that those muscles have significantly reduced myofibre necrosis when measured as a 
% of cross sectional area (% CSA), almost half the amount observed in chow fed mdx mice 
(Radley-Crabb et al., 2011). Furthermore, voluntarily exercised mdx mice on a high fat diet were 
able to run 50% further than their chow counterparts (Radley-Crabb et al., 2014).  
CLAMs data from this study revealed total and dual beam activity was always lower in 
mdx mice and mdx/Sln-null mice in comparison to WT mice with mdx mice having greater 
movement than mdx/Sln-null mice (Table 1). Despite no statistical significance, post-HFD mdx 
mice saw an 8.3% increase in cage activity; there was also an 9.5% increase in cage activity 
observed in mdx/Sln-null mice. Two possible explanations may account for the increase in 
activity in both mdx strains, (1) the high fat diet may be better suited to meeting the energy 
demands of the mdx and mdx/Sln-null mice and/or (2) the high fat diet may have altered the 
phospholipid membrane composition and reduced calcium leak from the SR/ER. Diets that are 
high in saturated fat and cholesterol can change the composition of the phospholipid membrane 
of skeletal muscles, particularly the incorporation of a higher percentage of saturated fatty acids 
in the muscle phospholipid membrane (Janovska et al., 2010). Alterations in the form of 
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increased saturated fatty acids and cholesterol in the phospholipid membrane of the SR have 
been found to reduce membrane fluidity thus reduce the rate of Ca2+ leak from the SR/ER 
(Vangheluwe et al., 2005). This reduction in Ca2+ could help reduce the dystropathology of mdx 
mice and improve muscle function. This could also help explain the decline of SLN in the 
diaphragm of HFD fed mdx mice. Calcium dysregulation in the muscle is one of the chief 
symptoms of Duchenne muscular dystrophy which contributes to its pathology (Franco-Obregon 
& Lansman, 1994; Turner, et al., 1991; Whitehead et al., 2006). The findings of the present study 
would suggest that the high fat diet may cause a compensatory decrease of SLN in mdx mice that 
could alleviate muscle necrosis and improve function. Furthermore, SLN expression remained 
upregulated despite a 30% decrease in comparison to pre-diet mdx mice. This suggests that 
despite the decline in SLN expression in response to high fat feeding, the already upregulated 
expression of SLN in mdx mice is large enough to maintain a significant difference in 
comparison to WT mice thereby maintaining SLN mediated thermogenesis in mdx mice. A 
future study may be needed to examine if the same decrease in expression occurs in mdx soleus 
due to it’s role in adaptive thermogenesis. These findings pose interesting future questions for 
high fat diet’s therapeutic role in DMD treatment.  
The ablation of sarcolipin results in a more efficient pumping of calcium into the SR (Bal 
et al., 2012), thus it was hypothesized that an overexpression of SLN would result in higher 
levels of SERCA uncoupling, increased energy expenditure, and protection against obesity 
(Maurya et al., 2015). After consuming an 8-week high fat diet, mice overexpressing SLN 
(SLNOE) were found to have lost weight and maintain a normal metabolic profile in comparison 
to WT mice and KO mice despite consuming significantly more calories than WT mice (Maurya 
et al., 2015).  For this study, it was hypothesized that the upregulated expression of SLN in mdx 
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mice would enhance adaptive thermogenesis and increase protection against diet-induced obesity 
and glucose intolerance. The body weights of WT and mdx mice were different pre-HFD with 
mdx mice (33.8 ± 0.58g) being heavier than WT mice (29.9 ± 0.73g). The significant differences 
in body weight pre-HFD can be attributed to pseudohypertrophy, a compensatory muscle 
hypertrophy due to muscle necrosis and replacement by connective tissue and fat in the muscles 
of mdx mice (Mokhatarian et al., 1996; Connolly et al., 2001; Coulton et al., 1988; Anderson et 
al, 1987). In contrast, post-HFD body weights of WT and mdx mice were not significantly 
different (43.1 ± 1.98g for WT vs 43.7 ± 1.98g for mdx) in accordance to previous findings 
which also observed no differences in final body weights (Radley-Crabb et al., 2011). The most 
likely explanation for a lack of a difference in bodyweight between WT and mdx mice after an 8-
week high fat diet is the increase in body fat in the WT mice (Figure 4d). 
Despite the lack of differences in final body weight post-HFD, as hypothesized WT mice 
experienced a 31% increase in body weight over the 8-week period. This demonstrates that the 
WT mice experienced greater weight gain (13.1 ± 1.15g) than mdx (9.0 ± 1.0g) or mdx/Sln-null 
(9.59 ± 0.92g) mice from week 2 of the high fat diet until its eventual completion (Fig. 2a). The 
weight gain observed in WT mice was in accordance with other studies examining weight gain 
over an 8-week high fat diet (Li et al., 2000; Collins et al., 2004; Bombardier, 2010). However, 
the weight gains observed in mdx mice were higher post HFD (171%) than the previously 
reported 137% increase (Radley-Crabb et al., 2014). One potential explanation could be a 
difference in the composition of the diets. The present study used a Western diet (TD 88137; 
Harlan Teklad, Madison, WI; 21.2% fat by weight; 42% of kcal from fat) whereas Radley-Crabb 
(2011) used a different high fat diet (SF06-040, Specialty Feeds, Glenn Forest, WA;16% fat by 
weight and 32% of kcal from fat) (Radley-Crabb, 2014). Furthermore, the diets varied in their 
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fatty acid profiles, with the Westernized high diet having 61.8% comprised of saturated fatty 
acids, whereas the high fat diet only had 3.26% composition of saturated fatty acids (Radley-
Crabb et al., 2011). Higher fat composition may have exacerbated weight gain in the mdx mice, 
thereby resulting in greater weight gain. This has been demonstrated across a variety of species 
and with various diets, with specific diets causing some species to gain more weight in 
comparison to other diets (Buettner et al., 2007). These findings further support that the 
composition of diet plays an important role in the manifestation of obesity.  
The ablation of sarcolipin has been shown to increase the efficiency of the SERCA 
pumps, predisposing SLN ablated mice to obesity after consuming a high fat diet (Bombardier, 
2010). In this study, it was hypothesized that the ablation of SLN in mdx mice would have 
similar effects to mdx/Sln-null mice, namely that they would be more susceptible to diet induced 
obesity and glucose intolerance when compared to mdx mice. Despite no statistical difference in 
weight gain between mdx and mdx/Sln-null mice, food consumption was significantly lower in 
mdx/Sln-null mice in comparison to mdx mice (Fig. 3). Thus, the mdx/Sln-null mice gained the 
same amount of weight as mdx mice despite consuming less of the high fat diet. The ablation of 
SLN blunts adaptive thermogenesis, resulting in higher metabolic efficiency, wherein less of the 
energy derived from ATP is dissipated as heat but rather stored and used as meaningful work. 
Higher metabolic efficiency makes it less likely that excess energy consumed from diet will be 
expended through thermogenic means, but instead stored as adipose tissue. Previous studies have 
shown that mice with increased metabolic efficiency, either through weight loss or the ablation 
of thermogenic proteins such as UCP-1, are more likely to gain weight and exhibit greater 
obesity (Maclean et al., 2004; Feldmann et al., 2007). Furthermore, Sln-null mice have exhibited 
enhanced metabolic efficiency, which was reflected in greater weight gain and adiposity in 
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comparison to WT mice (Rowland et al., 2016). As hypothesized, mdx/Sln-null mice displayed 
higher metabolic efficiency post-HFD than mdx mice (Fig. 6). Thus, mdx/Sln-null mice were less 
able to expend the extra calories ingested from the HFD in comparison to mdx mice which 
predisposed them to high fat diet induced obesity. One possible explanation for the difference in 
food consumption between mdx and mdx/Sln-null mice may be related to inflammatory 
cytokines. Elevated levels of TNF-α, IL1β, and IL-6 are a hallmark of mdx skeletal muscle 
dystropathology (Tidball et al., 2005). TNF-α, IL1β, and IL-6 have been found to increase leptin, 
a hormone that suppresses hunger and reduces food consumption, in a dose dependent manner 
(Saraff et al., 1997). A previous study examining the pathological impact of SLN ablation in mdx 
skeletal muscles found reduced myofiber area and greater muscle fibre breakdown with elevated 
serum creatine kinase (Fajardo, 2015). Due to enhanced mdx pathology, it is probable that 
mdx/Sln-null mice would also experience elevated levels of TNF-α, IL1β, and IL-6, wherein the 
fat expression and serum levels of leptin would increase and thereby reduce food consumption.  
The expansion of adipose tissue due to increased deposits of triacyglycerides (TAGs) into 
adipose depots is a common feature seen in rodent models of obesity (West and York, 1998). 
This study observed an approximately 2.8-9 fold higher fat pad weights in WT, mdx, and 
mdx/Sln-null mice post-HFD compared to chow fed counterparts (Fig. 3). Liver weights were 
significantly greater post-HFD across all three genotypes. When expressed as a percentage of 
body mass, the livers of high fat diet-fed animals comprised a larger percentage of body mass, 
particularly the WT and mdx/Sln-null mice (Fig. 5d). Interestingly, despite consuming a high fat 
diet, the liver % BW of mdx mice did not change. This may be an indication of mdx mice 
resistance to a high fat diet, since greater deposits of lipids in the liver is a common feature of 
obesity (Kontani et al., 2005; deLany and West, 2000).  
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As hypothesized, mdx/Sln-null mice had greater epididymal fat pad masses compared to 
mdx mice. The calculated adiposity index was highest in the WT mice displaying greater obesity 
than that of mdx and mdx/Sln-null mice. The adiposity index of mdx/Sln-null mice was 
significantly higher (P< 0.01) than mdx mice, thereby making mdx/Sln-null mice more obese. 
Despite differences in animal models, these results remain consistent with previous findings of 
increased high fat diet-induced obesity in SLN ablated mice (Bombardier, 2010). No differences 
in fat pad masses, BAT, or adiposity were observed between mdx and mdx/Sln-null pre-diet. 
These findings corroborated previous work (Bombardier, 2010; Gamu, 2012). 
Although mdx mice moved considerably less than WT mice, their waking VO2 was not 
significantly different prior to commencing their high fat diets. The higher waking, sleeping, and 
total daily VO2 (mlO2/kg/hr) observed in mdx mice post-HFD supports the hypothesis that mdx 
mice are better protected from obesity compared to WT mice due to increased SLN expression 
and increased energy expenditure. In contrast, pre-diet total daily VO2 and waking VO2 were 
significantly higher in mdx mice compared to mdx/Sln-null mice possibly due to the greater cage 
movement seen in mdx mice. There was a significant increase in absolute total daily VO2 across 
all three genotypes post-HFD where mdx mice had greater absolute VO2 values in comparison to 
WT mice. This is consistent with findings that mdx mice have greater energy expenditure than 
WT mice (Radley-Crabb et al., 2014). Mdx mice had greater waking and daily VO2 with respect 
to mdx/Sln-null mice, again supporting the hypothesis that mdx mice are better protected from 
obesity due to increased energy expenditure. Interestingly, there was no difference in all three 
absolute VO2 values between mdx/Sln-null and WT mice. This may seem paradoxical as weight 
gain and adiposity were significantly lower in mdx/Sln-null mice in comparison to WT mice. 
However, mdx/Sln-null mice moved considerably less than WT mice, thus mdx/Sln-null mice 
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have similar absolute VO2 values as WT mice despite a lower cage activity which would denote 
greater energy expenditure.  
Unexpectedly, the post-HFD sleeping VO2 values of mdx did not decrease substantially 
in comparison to mdx/Sln-null or WT mice. When examining absolute sleeping VO2 values, an 
18% increase in basal metabolism in mdx (P< 0.001) and mdx/Sln-null (P< 0.02) mice was 
observed with no significant difference between the two strains suggesting there was no 
difference in basal metabolism. The lack of a difference in basal metabolism is consistent with 
previous findings examining WT and Sln-null mice, which saw no difference in basal 
metabolism post-HFD (Bombardier, 2010). The ablation of SLN reduced the SERCA 
contribution to ATP consumption in Sln-null mice (Bombardier, 2010). As such mdx/Sln-null 
mice would experience a similar effect. Thus, other adaptive thermogenic mechanisms must be 
involved in increasing the energy expenditure of both mdx and mdx/Sln-null mice, with these 
mechanisms playing a greater role in mdx/Sln-null mice due to a decrease in SERCA energy 
consumption. One such mechanism is UCP-1 in the brown adipose tissue, which has been 
identified as a powerful agent of adaptive thermogenesis (Lowell and Spiegelman, 2000). Post-
HFD weights of BAT were significantly higher (P< 0.05) in mdx/Sln-null mice in comparison to 
mdx mice and significantly lower than WT mice. This would suggest that when compared to mdx 
mice, the increase in energy expenditure in mdx/Sln-null mice could be accounted for by 
increases in UCP-1 expression. However, despite significant increases in UCP-1 expression post-
HFD, there was no significant difference in UCP-1 expression across all three genotypes (Figure 
7). Thus, the increase in energy expenditure and the differences in adiposity could not be 
accounted for by the increased expression of UCP-1 nor could it explain the increased basal 
metabolism of both mdx and mdx/Sln-null mice. However, as the name implies, UCP-1 is not the 
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only uncoupling protein, UCP-3 is another mitochondrial uncoupling protein found in BAT and 
skeletal muscle. UCP-3 expression has been upregulated in response to high fat feeding and 
obesity (Schrauwen et al., 2001), although it’s importance to thermogenesis is tentative at best as 
UCP-3 ablation studies have not shown a significant reduction in whole body energy expenditure 
(Vidal-Puig et al., 2000; Hoeks et al., 2006). Previous studies have shown that mdx mice do not 
have significant differences in the expression of UCP-3 in comparison to WT mice (Perceival et 
al., 2013). However, this was observed under chow fed conditions and there has yet to be a study 
examining the effect of HFD on the expression of UCP-3 of mdx mice. It can be speculated that 
HFD could potentially increase the expression of UCP-3 in mdx and/or mdx/Sln-null mice, 
thereby increasing their basal metabolic rate. Another consideration is the upregulation of 
phospholamban (PLN) in BAT tissue. PLN is an SLN homologue and possesses a similar 
capacity to uncouple Ca2+ transport from ATP hydrolysis (Frank et al., 2000). PLN has been 
found to be upregulated in the BAT tissue of both WT and Sln-null mice fed a HFD 
(Bombardier, 2010). Although not examined in this study, there is a possibility that the 
expression of PLN may have been upregulated in mdx and mdx/Sln-null causing an increase in 
basal metabolism which may account for the lack of a difference in UCP-1 expression and higher 
BAT mass in mdx/Sln-null mice. Another possible explanation for the similar basal metabolism 
of mdx and mdx/Sln-null mice is the upregulation of catecholamines. Norepinephrine (NE) and 
epinephrine (E) have been found to be elevated in the HFD fed Sln-null mice (Bombardier, 
2010). It has been established that an increase in sympathetic nervous system (SNS) activity 
augments energy metabolism and thermogenesis (Maickel et al., 1967; Cannon and Nedergrad, 
2003). mdx mice have been found to have heightened sympathetic nervous activity (Chu, 2002), 
however there is very little literature regarding the levels of catecholamines in mdx mice. 
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Although not examined in the present study, hindlimb perfusion experiments in rats have 
demonstrated the ability of NE to stimulate skeletal muscle VO2 potentially through increased 
activity of the Na+-K+ ATPase (Clausen, 1986; Shiota and Masumi, 1988). Thus, it is possible 
that higher catecholamine levels in mdx/Sln-null mice post HFD could partly account for the 
higher absolute basal VO2. 
Despite not knowing the precise mechanisms underlying lower total whole metabolic rate 
in mdx/Sln-null mice, the fact remains that mdx/Sln-null mice were more obese and glucose 
intolerant than HFD fed mdx littermates. Glucose tolerance responses in WT and mdx mice pre-
HFD were consistent with previous studies with mdx mice demonstrating greater glucose 
intolerance than WT mice (Stapleton, 2014). After high fat feeding, WT mice exhibited reduced 
glucose tolerance comparable to mdx mice; mdx mice exhibited no difference from pre-HFD 
glucose tolerance. In contrast, glucose tolerance responses between mdx and mdx/Sln-null mice 
were not different pre-HFD; however as hypothesized, mdx/Sln-null mice demonstrated a greater 
glucose intolerance than mdx and WT mice post-HFD (Figure 5). The greater glucose intolerance 
observed in WT mice is consistent with previous high fat feeding studies that saw a comparable 
increase in blood glucose following the consumption of a 42% Westernized diet (Li et al., 2000; 
Bombardier, 2010; Gamu, 2012). While not directly assessed here, the observed glucose 
intolerance in both WT and mdx/Sln-null mice may be reflective of reduced skeletal muscle 
insulin stimulated uptake of glucose. It has been demonstrated that elevated levels of plasma free 
fatty acids (FFA) play a major role in reduced skeletal muscle insulin sensitivity (Kashyap et al., 
2003, Roden et al., 1996). However, if elevated FFAs played a role in glucose intolerance, mdx 
mice should have experienced a greater glucose intolerance after high fat diet which was not 
observed. Interestingly, mdx/Sln-null mice experienced a greater severity of glucose intolerance 
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in comparison to mdx mice. A possible explanation for this may be related to cytoarchitecture of 
mdx and mdx/Sln-null mice. Glucose metabolism involves the translocation of glucose 
transporter 4 (GLUT4) from the cytoplasm to the sarcolemma either due to insulin dependent or 
independent signaling pathways. An intact cell membrane and cortical actin system is needed to 
allow the fusion of GLUT4-loaded vesicles with the sarcolemma, in addition to a functioning 
microtubule (MT) network for long-distance vesicle transport. Mdx mice membranes are 
characterized by their fragility due to the lack of dystrophin, leaving their muscles vulnerable to 
mechanical stress and damage. The lack of dystrophin compromises the integrity of the cell 
membrane, thereby disrupting the proper translocation of GLUT4 to the sarcolemma. Utrophin, a 
dystrophin homologue, is highly upregulated in the membrane of mdx muscles as a 
compensatory protein to make up for the lack of dystrophin in the cytoarchitecture. Mdx/Sln-null 
mice have been found with lower expression of utrophin, which further compromises membrane 
integrity as evidenced by lower muscle CSA% and higher creatine kinase in comparison to mdx 
mice (Fajardo, 2015). Thus, the worsened membrane integrity of mdx/Sln-null mice may further 
inhibit the translocation of GLUT4 to the sarcolemma resulting in greater glucose intolerance. 
Other potential mechanisms may contribute to the greater glucose intolerance in mdx/Sln-null 
mice compared to mdx mice. Adiponectin, an insulin sensitizing agent, levels may have been 
reduced due to increased obesity (Arita et al., 2000). Also, there may have been a greater 
inflammation of adipose tissue related to the hypertrophy of adipocytes causing an elevation of 
inflammatory cytokines such as TNF-α (Guilherme et al., 2008). As evidence by the greater 
adiposity of mdx/Sln-null mice following high fat feeding, it would seem that both of these 
mechanisms may a play a role in a greater glucose intolerance, as both mechanisms have been 
shown to decrease glucose uptake (Dycke et al., 2006; Guilherme et al., 2008).  
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Summary and Conclusions 
 In summary, this study demonstrates that the ablation of SLN in mdx mice resulted in 
greater obesity and glucose intolerance potentially due to the lower daily energy expenditure 
seen in mdx/Sln-null mice compared to mdx mice following a HFD. Furthermore, mdx mice were 
found to be protected from obesity due to greater daily energy expenditure seen in mdx mice in 
comparison to WT mice. Western blotting revealed that SLN expression was 2-fold higher in the 
diaphragm of mdx mice compared to WT mice, the elevated levels of SLN was still observed in 
HFD fed mdx mice despite a 30% decline. Much like previous studies from our laboratory, the 
ablation of SLN mdx mice manifested in greater adiposity and poorer glucose tolerance after the 
consumption of an 8-week high fat diet. Glucose tolerance did not change after HFD in mdx 
mice, whereas mdx/Sln-null mice glucose tolerance was more severe than WT and mdx mice, 
possibly due to a decrease in membrane integrity brought upon by a possible decline in utrophin 
expression. Taken altogether, these data suggest that SLN plays an important role in adaptive 
thermogenesis in mdx mice. 
Limitations 
 There were a variety of limitations for this study. First, this study was unable to provide a 
successful detection of SLN in soleus despite our best efforts. Previous studies performed in our 
laboratory have done so successfully and such information would have provided more 
meaningful insight into the role of SLN in adaptive thermogenesis in mdx mice. This may have 
been the result of technical issues and/or the quality of the soleus muscle prep which should be 
addressed in future projects. Secondly, the role of UCP-3 in thermogenesis was not assessed, 
thus their role with respect to enhanced basal metabolism in mdx and mdx/Sln-null mice is only 
speculative. Thirdly, efforts were made to maintain consistent environmental conditions, 
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however one cohort of mice were housed in a high humidity (80-85% relative humidity) 
environment due to a faulty environmental control system within that wing of the central animal 
facility. As the animals were already into their diets, dehumidifiers were used to try and mitigate 
the elevation in humidity. However, dehumidifiers were found to be noisy and had to be cleared 
of excess water every 12 hours. The added noise from the humidifiers and effort to empty them 
may have elicited a greater stress response in these animals affecting food consumption and VO2 
measurements.   
Future Directions 
 With relevance to adaptive thermogenesis, it would be interesting to examine the relative 
contribution of UCP-1 to the increased basal metabolism seen in mdx/Sln-null mice. Although, 
the expression of UCP-1 was not different between mdx and mdx/Sln-null mice, BAT weights 
were significantly higher in mdx/Sln-null mice. The ablation of UCP-1 has been shown to cause 
diet-induced obesity (Feldmann et al., 2009), it would be of interest to observe if BAT played a 
larger role in elevating basal metabolism post-HFD in mdx/Sln-null mice versus mdx mice. A 
future study examining mdx/Sln-null mice with their BAT surgically removed could provide 
insight into this. Other potential thermogenic mechanisms, such as UCP-3, should be explored as 
they may explain the elevation in sleeping VO2 observed in both mdx and mdx/Sln-null mice.   
The role of catecholamines in enhancing basal metabolism of both mdx and mdx/Sln-null 
should be examined more thoroughly. NE and E levels should be measured in future high fat 
feeding studies to observe whether elevations may have caused subsequent increases in VO2 
Post-HFD. This interest is due to the potential role of catecholamines in augmenting fat 
lipolysis/de novo synthesis via AMPK activation in skeletal muscle (Dulloo et al., 2004). 
Furthermore, elevated catecholamines act on adipocytes resulting in the activation of G couple 
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protein receptors in adipocytes and the stimulation of adenylyl cyclase leading to the elevation of 
cyclic AMP, ultimately increasing the blood levels of NEFA, through the activation of hormone 
sensitive lipase, which is known to cause glucose intolerance and insulin resistance (Roden et al., 
1996). A comparative chow group will need to be done as well, as information regarding 
catecholamine levels in mdx mice has yet to have been reported. Also, it would be beneficial to 
examine NEFA levels as well as mdx mice did not experience poorer glucose tolerance after a 
HFD. 
The role of cytoarchitecture with respect to glucose tolerance should be examine more 
thoroughly. The loss of dystrophin has been associated with a subsequent worsening of glucose 
tolerance due to an inability to properly translocate GLUT4 to the sarcolemma of mdx mice. 
Post-HFD mdx blood glucose values did not worsen after a high fat diet, while mdx/Sln-null mice 
saw a significant worsening of their glucose intolerance. Future studies should examine whether 
utrophin (utr) expression is a key protein with respect to GLUT4 translocation. Animals for such 
a study may be difficult for a high fat feeding study, as mdx utr -/- mice have limited life spans 
and often die prematurely before reaching the 3-4-months age of mdx controls (McDonald et al., 
2015). As such it proposed that a heterozygote model, mdx utr +/-, may provide an intermediate 
model. These utr heterozygous mdx mice display greater pathology than mdx mice but less than 
mdx utr -/- mice and their lifespans are almost normal in comparison to the short life spans of 
mdx utr -/- animals. Furthermore, these animals display haploinsufficient expression of utrophin 
and could provide further insight into the role of utrophin and glucose tolerance. 
 
 
 
45 
 
References 
Anderson, J. E., Ovalle, W. K., & Bressler, B. H. (1987). Electron microscopic and 
autoradiographic characterization of hindlimb muscle regeneration in the mdx 
mouse. Anatomical Record, 219(3), 243-257. 
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.,…Matsuzawa, Y. 
(1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in 
obesity. Biochemical and Biophysical Research Communications, 257, 79-83. 
Asahi, M., Sugita, Y., Kurzydlowski, K., De Leon, S., Tada, M., Toyoshima, C., & 
MacLennan, D. H. (2003). Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase 
(SERCA) by binding to transmembrane helicies alone or in association with 
phospholamban. Pnas, 100(9), 5040-5045. 
Bal, N. C., Maurya, S. L., Sopariwala, D. H., Sahoo, S. K., Gupta, S. C., Shaikh, S. A., & 
Periasamy, M. (2012). Sarcolipin is a newly identified regulator of muscle-based 
thermogenesis in mammals. Nature Medicine, 18(10), 1575-1579. doi:10.1038/nm.2897 
Berchtold, M. W., et al. (2000). "Calcium Ion in Skeletal Muscle: Its Crucial Role for Muscle 
Function, Plasticity, and Disease." Physiological Reviews 80(3): 1215-1265. 
Berman MC. Slippage and uncoupling in P-type cation pumps; implications for energy 
transduction mechanisms and regulation of metabolism. Biochem. Biophys. Acta. 1513: 95-
121, 2001. 
46 
 
Blake, D. J., Weir, A., Newey, S. E., & Davies, K. E. (2002). Function and Genetics of 
Dystrophin and Dystrophin-Related Proteins in Muscle. Physiological Reviews, 82(2), 291-
329. 
Bombardier, E., Smith, I. C., Gamu, D., Fajardo, V. A., Vigna, C., Sayer, R. A., & Tupling, 
A. R. (2013). Sarcolipin trumps Beta-Adrenergic receptor signaling as the favored 
mechanism for muscle based diet-induced thermogenesis. FASEB J, 2(7), 3871-3878. 
Bombardier, E., Smith, I. C., Vigna, C., Fajardo, V. A., & Tupling, A. R. (2013). Ablation of 
sarcolipin decreases the energy requirements for Ca2+ transport by sarco(endo)plasmic 
reticulum Ca2+-ATPases in resting skeletal muscle. FEBS Letters, 587, 1687-1692. 
Bombarider, E. (2010). The Role of Sarcolipin in Calcium Handling and 
Obesity. (Unpublished Phd Thesis). University of Waterloo, Waterloo, Ontario, Canada. 
Bonilla, E., Samitt, C. E., Miranda, A. F., Hays, A. P., Salviati, G., DiMauro, S., & Rowland, 
L. P. (1988). Duchenne Muscular Dystrophy: Defiency of Dystrophin at the Muscle Cell 
Surface. Cell, 54, 447-452. 
Buettner, R., Schölmerich, J., & Bollheimer, L. C.High-fat diets: modeling the metabolic 
disorders of human obesity in rodents.. Obesity, 15(4), 798-808. 
Bulfield, G., Siller, W. G., Wight, P. A. L., & Moore, K. J. (1984). X chromosome-linked 
muscular dystrophy (mdx) in the mouse. 81. 1189-1192. 
Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. 
Physiol. Rev. 2004; 84(1):277Y359. 
47 
 
Cannon, B., & Nedergard, J. (2003). Brown Adipose Tissue: Function and physiological 
significance. Physiological Reviews, 84, 277-359. 
Chu, V., Otero, J. M., Lopez, O., Sullivan, M. F., Morgan, J. P., Amende, I., & Hampton, T. 
G. (2002). Electrocardiographic findings in mdx mice: A cardiac phenotype of Duchenne 
muscular dystrophy. Muscle and Nerve, 26(4), 513-519. 
Clausen, T. (1986). Regulation of active Na+-K+ transport in skeletal muscle. Physiological 
Reviews, (542), 580. 
Collins, S., Martin, T. L., Surwit, R. S., & Robidoux, J. (2004). Genetic vulnerability to diet-
induced obesity in the C57BL/6J mouse: physiological and molecular 
characteristics. Physiology and Behavior, 81(2), 243-248. 
Connolly, A. M., Keeling, R. M., Mehta, S., Pestronk, A., & Sanes, J. R. (2001). Three 
mouse models of muscular dystrophy: the natural history of strength and fatigue in 
dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice. Neuromuscular 
Disorders, 11(8), 703-712. 
Coulton, G. R., Curtin, N. A., Morgan, J. E., & Partridge, T. A. (1988). The mdx mouse 
skeletal muscle myopathy: II. Contractile properties. Neuropathology and Applied 
Neurobiology, 14(4), 299-314. 
Culligan, K., Banville, N., Downling, P., & Ohlendieck, K. (2002). Drastic reduction of 
calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle. Journal 
of Applied Physiology, 92, 435-445. 
48 
 
de Meis L. Role of the sarcoplasmic reticulum Ca2+-ATPase on heat production and 
thermogenesis. Biosci. Rep. 21: 113-137, 2001b. 
de Meis L. Uncoupled ATPase activity and heat production by the sarcoplasmic reticulum 
Ca2+-ATPase: Regulation by ADP. J. Biol. Chem. 276: 25078-25087, 2001a. 
deLany, J. P., & West, D. B. (2000). Changes in body composition with conjugated linoleic 
acid. Journal of the American College of Nutrition, 19, 487S-493S. 
Dulhunty, A.F. (2006). Excitation-contraction coupling from the 1950s into the new 
millennium. Clin ExPPharmacol Physiol. 33: 763-772. 
Dulloo, A. G., Gubler, M., Montani, J. P., Seydoux, J., & Solinas, G. (2004). Substrate 
cycling between de novo lipogenesis and lipid oxidation: a thermogenic mechanism against 
skeletal muscle lipotoxicity and glucolipotoxicity. International Journal of Obesity, 28, S29-
S37. 
Dupont-Versteegden, E. E., Baldwin, R. A., McCarter, R. J., & Vonlanthen, M. G. (1994). 
Does Muscular Dystrophy Affect Metabolic Rate? A Study in mdx mice. Journal of 
Neurological Sciences, 121, 203-207. 
Dyck, D. J., Heigenhauser, G. J. F., & Bruce, C. R. (2006). The role of adipokines as 
regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta 
Physiologica, 185, 5-16. 
Fajardo, V. A. (2015). The Role of Phospholamban and Sarcolipin in Skeletal Muscle 
Disease. (Unpublished Phd Thesis). University of Waterloo, Waterloo, Ontario, Canada. 
49 
 
Feldmann, H. M., Golozoubova, V., Cannon, B., & Nedergaard, J. (2009). UCP1 Ablation 
Induces Obesity and Abolishes Diet-Induced Thermogenesis in Mice Exempt from Thermal 
Stress by Living at Thermoneutrality. Cell Metabolism, 9(2), 203-209. 
Feldmann, H.M., Golozoubova, V., Cannon, B., and Nedergaard, J. (2009). UCP-1 ablation 
induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal 
stress by living at thermoneutrality. Cell Metab. 9: 203-209. 
 
Franco-Obregon Jr A, Lansman JB. Mechanosensitive ion channels in skeletal muscle from 
normal and dystrophic mice. J. Physiol. 1994; 481: 299–309. 
Frank, K., Tilgmann, C., Shannon, T. R., Bers, D. M., & Kranias, E. G. (2000). Regulatory 
Role of Phospholamban in the Efficiency of Cardiac Sarcoplasmic Reticulum Ca2+ 
Transport. Biochemical Journal, 39, 14176-14182. 
Gailly P. (2002) New aspects of calcium signaling in skeletal muscle cells: implications in 
Duchenne muscular dystrophy. Biochim Biophys Acta 1600(1-2):38-44. 
Gamu, D. (2012). Examination of Voluntary Wheel Running and Skeletal Muscle Metabolism 
in the Sarcolipin Knock-Out Mouse. (Unpublished Master's Thesis). University of Waterloo, 
Waterloo, Ontario, Canada. 
Garcia-Pelagio, K. P., Bloch, R. J., Ortega, A., & Gonzalez-Serratos, H. (2011). 
Biomechanics of the sarcolemma and costameres in single skeletal muscle fibers from 
normal and dystrophin-null mice. Journal of Muscle Research and Cell Motility, 31(0), 323-
336. doi:10.1007/s10974-011-9238-9 
50 
 
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008). Adipocytes dysfunctions 
linking obesity to insulin resistance and type 2 diabetes. Nature Reviews Molecular Cell 
Biology, 9, 367-377. 
Hoeks, J., Hesselink, M. K., & Schrauwen, P. (2006). Involvement of UCP3 in mild 
uncoupling and lipotoxicity. Experimental Gerontology, 41(7), 658-662. 
Janovska, A., Hatzinikolas, G., Mano, M., & Wittert, G. A. (2010). The effect of dietary fat 
content on phospholipid fatty acid profile is muscle fibre-type dependent. American Journal 
of Physiology, 298(4), E779-E786. 
Kashyap, S., Belfort, R., Gastaldelli, A., Pratipanawatr, T., Berria, R., Pratipanawatr, W., . . . 
Cusi, K. (2003). A sustained increase in plasma free fatty acids impairs insulin secretion in 
nondiabetic subjects genetically predisposed to develoPtype 2 diabetes. Diabetes, 52(10), 
2461-2474. 
Kontani, Y., Wang, Y., Kimura, K., Inokuma, K. I., Saito, M., Suzuki-Miura, T., . . . 
Yamashita, H. (2005). UCP1 deficiency increases susceptibility to diet-induced obesity with 
age. Aging Cell, 4(3), 147-155. 
Kuznetsov AV, Winkler K, Wiedemann FR, von Bossanyi P, Dietzmann K, Kunz WS. 
Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-
deficient mdx mouse. Mol. Cell. Biochem. 1998; 183: 87–96. 
51 
 
Li, B., Nolte, L. A., Ju, J., Han, D. H., Coleman, T., Holloszy, J. O., & Semenkovich, C. F. 
(2000). Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin 
resistance in mice. Nature Medicine, 6(10), 1115-1120. 
MacLean, P. S., Higgins, J. A., Johnson, G. C., Fleming-Elder, B. K., Donahoo, W. T., 
Melanson, E. L., & Hill, J. O. (2004). Enhanced metabolic efficiency contributes to weight 
regain after weight loss in obesity-prone rats. American Journal of Physiology Regulatory 
Integrative and Comparative Physiology, 287(6), 1306-1315. 
MacLennan, D. H., Asahi, M., & Tupling, A. R. (2003). The regulation of SERCA-type 
pumps by phospholamban and sarcolipin. Annals of the New York Academy of Sciences, 986, 
472-480. 
Maickel, R. P., Matussek, N., Stern, D. N., & Brodie, B. B. (1967). The sympathetic nervous 
system as a homeostatic mechanism. I. Absolute need for sympathetic nervous function in 
body temperature maintenance of cold-exposed rats. Journal of Phamacology and 
Experimental Therapeutics, 157(1), 103-110. 
Mall S, Broadbridge R, Harrison SL, Gore MG, Lee AG and East JM. The presence of 
sarcolipin results in increased heat production by Ca2+-ATPase. J. Biol. Chem. 281: 36597-
36602, 2006. 
Martonosi AN & Pikula S (2003) The network of calcium regulation in muscle. Acta 
Biochim Pol 50(1):1-30.  
Maurya, S. K., Bal, N. C., Sopariwala, D. H., Pant, M., Rowland, L. A., Shaikh, S. A., & 
Periasamy, M. (2015). Sarcolipin Is a Key Determinant of the Basal Metabolic Rate, and Its 
52 
 
Overexpression Enhances Energy Expenditure and Resistance against Diet-induced 
Obesity. The Journal of Biological Chemistry, 290(17), January 25, 2017. doi:- 
10.1074/jbc.M115.636878 
McDonald, A. A., Herbert, S. L., Kunz, M. D., RAlles, S. J., & McLoon, L. K. 
(2015). Disease course in mdx:utrophin+/− mice: comparison of three mouse models of 
Duchenne muscular dystrophy.Physiological Reports, 3(4) doi:10.14814/phy2.12391 
McGreevy, J. W., Hakim, C. H., McIntosh, M. A., & Duan, D. (2015). Animal models of 
Duchenne muscular dstrophy: from basic mechanisms to gene therapy. The Company of 
Biologists Disease Models and Mechanisms, 8, 195-213. 
Mokhtarian, A., Decrouy, A., Chinet, A., & Even, P. C. (1996). Components of energy 
expenditure in the mdx mouse model of Duchene muscular dystrophy. European Journal of 
Physiology, 431, 527-532. 
Percival, J. M., Siegel, M. P., Knowels, G., & Marcinek, D. J. (2013). Defects in 
mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne 
muscular dystrophy are not alleviated by PDE5 inhibition. Human Molecular 
Genetics, 22(1), 153-167. 
Pertille, A., Tonizza de Carvallo, C. L., Matsumura, C. Y., Neto, H. S., & Marques, M. J. 
(2010). Calcium-binding proteins in skeletal muscles of the mdx mice: potential role in the 
pathogenesis of Duchenne muscular dystrophy. International Journal of Experimental 
Pathology, 91, 63-71. 
53 
 
Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., & Sweeney, H. L. (1993). 
Dystrophin protects the sarcolemma from stresses during muscle contraction. Proceedings of 
the National Academy of Sciences of the United States of America, 90, 3710-3714.  
Radley, H. G., De Luca, A., Lynch, G. S., & Grounds, M. D. (2007). Duchenne muscular 
dystrophy: Focus on pharmaceutical and nutritional interventions. The International Journal 
of Biochemistry & Cell Biology, 39, 469-477. 
Radley-Crabb, H. G., Fiorotto, M. L., & Grounds, M. D. (2011). The different impact of a 
high fat diet on dystrophic mdx and control C57Bl/10 mice. PLOS Currents Muscular 
Dystrophy, (1) doi:10.1371/currents.RRN1276. 
Radley-Crabb, H. G., Marini, J. C., Sosa, H. A., Castillo, L. I., Grounds, M. D., & Fiorotto, 
M. L. (2014). Dystropathology Increases Energy Expenditure and Protein Turnover in the 
Mdx Mouse Model of Duchenne Muscular Dystrophy. PLOS One, 9(2), 1-13. 
doi:10.1371/journal.pone.0089277 
Reis M, Farage M and de Meis L. Thermogenesis and energy expenditure: control of heat 
production by the Ca2+-ATPase of fast and slow muscle. Mol. Mem. Biol. 19: 301-310, 
2002. 
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & 
Shulman, G. I. (1996). Mechanism of free fatty acid-induced insulin resistance in 
humans. Journal of Clinical Investigation, 97, 2859-2865. 
54 
 
Rolfe, D. F., & Brown, G. C. (1997). Cellular energy utilization and molecular origin of 
standard metabolic rate in mammals. Physiological Reviews, 77, 731-758. 
Rowland, L. A., Maurya, S. K., Bal, N. C., Kozak, L., & Periasamy, M. (2016). Sarcolipin 
and uncoupling protein 1 play distinct roles in diet-induced thermogenesis and do not 
compensate for one another..Obesity, 24(7), 1430-1433. 
Sarraf, P., Frederich, R. C., Turner, E. M., Ma, G., Jaskowiak, N. T., Rivet, D. J., . . . 
Alexander, H. R. (1997). Multiple cytokines and acute inflammation raise mouse leptin 
levels: potential role in inflammatory anorexia. The Journal of Experimental 
Medicine, 185(1), 171-175. 
Schiaffino S & Reggiani C (2011) Fiber types in mammalian skeletal muscles. Physiol Rev 
91(4):1447-1531. 
Schneider, J. S., SHanmugam, M., Gonzalez, J. S., Lopez, H., Gordan, R., Fraidenraich, D., 
& Babu, G. J. (2013). Increased sarcolipin expression and decreased sarco(endo)plasmic 
reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular 
dystrophy. Journal of Muscle Research and Cell Motility,34, 349-356. doi:10.1007/s10974-
013-9350-0 
Schrauwen, P., Hoppeler, H., Billeter, R., Bakker, A., & Pendergast, D. (2001). Fibre type 
dependent upregulation of human skeletal muscle UCP2 and UCP3 mRNA expression by 
high fat diet. International Journal of Obesity and Related Metabolic Disorders, 25(4), 449-
456. 
55 
 
Shiota, M., & Masumi, S. (1988). Effect of norepinephrine on consumption of oxygen in 
perfused skeletal muscle from cold exposed rats. American Journal of Physiology, 254, 
E482-E489. 
Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G., & Barnard, P. J. 
(1989). The Molecular Basis of Muscular Dystrophy in the mdx Mouse: A Point 
Mutation. Science, 244, 1578-1579. 
Smith, I. C., Bombardier, E., Vigna, C., & Tupling, A. R. (2013). ATPConsumption by 
Sarcoplasmic Reticulum Ca2+ Pumps Accounts for 40-50% of Resting Metabolic Rate in 
Mouse Fast and Slow Twitch Skeletal Muscle. PLOS One, 8(7), 1-11. 
Smith, W. S., Broadbridge, R., East, J. M., & Lee, A. G. (2002). Sarcolipin uncouples the 
hydrolysis of ATPfrom accumulation of Ca2+ by the Ca2+-ATPase of the skeletal-muscle 
sarcoplasmic reticulum. Biochemical Journal, 361, 277-286. 
Son, C., Hosoda, K., Ishihara, K., Bevilaqua, L., Masuzaki, H., Fushiki, T., Harper, M.E., 
and Nakao, K. (2004). Reduction in diet-induced obesity in transgenic mice overexpressing 
uncoupling protein 3 in skeletal muscle. Diabetologia. 47: 47-54. 
Spencer MJ, Croall DE, Tidball JG. Calpains are activated in necrotic fibers from mdx 
dystrophic mice. J. Biol. Chem. 1995; 270: 10 909–914 
Stammers, A. N., et al. (2015). "The regulation of sarco(endo)plasmic reticulum calcium-
ATPases (SERCA)." Canadian Journal of Physiology and Pharmacology 93(10): 843-854. 
56 
 
Stapleton, D. I., Lau, X., Flores, M., Trieu, J., Gehrig, S. M., Chee, A., . . . Koopman, R. 
(2014). Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice. PLOS 
One, 9(3) doi:10.1371/journal.pone.0091514 
Tidball, J. G. (2005). Inflammatory processes in muscle injury and repair. American Journal 
of Physiology Regulatory Integrative and Comparative Physiology, 288(2), 345-353. 
Toyoshima C & Inesi G (2004) Structural basis of ion pumping by Ca2+-ATPase of the 
sarcoplasmic reticulum. Annu Rev Biochem 73:269-292. 
Toyoshima C, Nakasako M, Nomura H, & Ogawa H (2000) Crystal structure of the calcium 
pumPof sarcoplasmic reticulum at 2.6 A resolution. Nature 405(6787):647-655. 
Toyoshima, C. (2007). Ion Pumping by Calcium ATPase of sarcoplasmic 
reticulum. Advances in Experimental Medicine and Biology, 592, 295-303. 
Tupling, A. R., Bombardier, E., Gupta, S. C., Hussain, D., Vigna, C., Bloemberg, D., & 
Gramolini, A. O. (2011). Enhanced Ca2+ transport and muscle relaxation in skeletal muscle 
from sarcolipin-null mice. American Journal of Physiology Cell Physiology, 301, 841-849. 
Turner PR, Fong PY, Denetclaw WF, Steinhardt RA. Increased calcium influx in dystrophic 
muscle. J. Cell Biol. 1991; 115: 1701–12. 
Turner, P. R., Westwood, T., Regen, C. M., & Steinhardt, R. A. (1988). Increased protein 
degradation results from elevated free calcium levels found in muscle from mdx 
mice. Nature, 335, 735-738. 
57 
 
Vangheluwe P, Schuermans M, Zador E, Waelkens E and Raeymaekers L.(2005a) Sarcolipin 
and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different 
species. Biochem. J. 389: 151-159. 
Vaugheluwe, P., Raeymaekers, L., Dode, L., & Wuytack, F. (2005b). Modulating 
sarco(endo)plasmic reticulum Ca2+ ATPase 2 (SERCA2) activity: cell biological 
implications. Cell Calcium, 38, 291-302. 
Vidal-Puig, A., Solanes, G., Grujic, D., Flier, J.S., and Lowell, B.B. (1997). UCP3: An 
uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle 
and brown adipose tissue. Biochem Biophys Res Commun. 235: 79-82. 
Vidal-Puig, A.J., Grujic, D., Zhang, C.Y., Hagan, T., Boss, O., Ido, Y., Szczepanik, A., 
Wade, J., Mootha, V., Cortright, C., Muoio, D.M., and Lowell, B.B. (2000). Energy 
metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem. 275: 16258–16266. 
Voit A., Patel V., Pachon R., Shah V., Bakhutma M., Kohlbrenner E., McArdle J.J., 
Dell'Italia L.J., Mendell J.R., Xie LH, Hajjar R.J., Duan D., Fraidenraich D., Babu G.J. 
(2017). Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and 
associated cardiomyopathy in mice. Nature Communications, 8(1). 1068. 
West, D. B., & York, B. (1998). Dietary fat, genetic predisposition, and obesity: lessons from 
animal models. American Journal of Clinical Nutrition, 67(3 suppl), 505S-512S. 
Whitehead, N. P., et al. (2006). "Muscle Damage in mdx (Dystrophic) mice: Role of Calcium 
and Reactive Oxygen Species." Clinical and Experimental Pharmacology and Physiology 
33(7): 657-662. 
58 
 
Willmann, R., Possekel, S., Dubach-Powell, J., & Meier, M. (19). Mammalian animal models 
for Duchenne muscular dystrophy. 2009. 241-249. 
Woods, C. E., Novo, D., DiFranco, M., & Vergara, J. L. (2004). The action potential-evoked 
sarcoplasmic reticulum calcium release is impaired in mdx mouse muscle fibres. Journal of 
Physiology, 557(1), 59-75.  
Zanardi, M. C., Tagliabue, A., Orcesi, S., Berardinelli, A., Uggetti, C., & Pichiecchio, A. 
(2003). Body composition and energy expenditure in Duchene muscular 
dystrophy. European Journal of Clinical Nutrition, 57, 273-278. 
 
 
 
 
 
 
 
 
 
 
 
 
 
59 
 
Appendix A: Supplementary Results 
 
 
 
 
 
Figure A1. No differences in the change in body mass across all three genotypes, with mdx/ 
mdx/Sln-null mice having greater bodyweight pre- and post-Chow diet. A) Change in body 
mass of wild-type (WT), mdx, and mdx/Sln-null mice during 8 weeks of a Chow diet. B) Pre- 
and Post-Chow bodyweights of WT, mdx, and mdx/Sln-null mice. Values are mean ± S.E. * 
Significantly different than corresponding mdx and mdx/Sln-null (P < 0.05). (WT: n = 11, 
mdx: n = 13, mdx/Sln-null; n = 8) 
  
Figure A2. A) Total Food Consumption across 8 weeks of chow diet for wild-type (WT), mdx, 
and mdx/Sln-null mice. B) Glucose AUC *Significantly different from WT mice. Values are 
mean ± S.E. * Significantly different than mdx (P < 0.05). WT: n = 11, mdx: n = 13, mdx/Sln-
null; n = 8) 
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Table A1.  CLAMS Measurements of Wild type (WT), mdx, and mdx/Sln-null mice Pre and Post Chow  
 
 Pre Post 
 WT mdx mdx/Sln-null WT mdx mdx/Sln-null 
 
Body Weight 
(g) 
 
 
29.7 ± 0.91 
 
 
33.4 ± 0.52# 
 
34.6 ± 1.1# 
 
33.6 ± 0.97 
 
37.0 ± 0.64*# 
 
40.5 ± 1.54*# 
 
Waking VO2 
(ml O2/kg/hr) 
 
 
3562 ± 41 
 
3498 ± 65# 
 
3224 ± 67#$ 
 
3192 ± 76* 
 
3268 ± 68*# 
 
2952 ± 63*#$ 
 
Sleeping VO2 
(ml O2/kg/hr) 
 
 
2793 ± 68 
 
2775 ± 80# 
 
2440 ± 52#$ 
 
2529± 62* 
 
2547 ± 83* 
 
2260 ± 77*#$ 
 
Total Daily 
VO2 (ml 
O2/kg/hr) 
 
 
 
3319 ± 32 
 
 
3291 ± 73# 
 
 
2899 ± 66#$ 
 
 
2963 ± 56* 
 
 
3069 ± 46*# 
 
 
2705 ± 63*#$ 
 
Food Intake 
(g) 
 
 
4.11 ± 0.18 
 
4.26 ± 0.17 
 
 
4.16 ± 0.22 
 
 
4.17 ± 0.16 
 
3.94 ± 0.09 
 
 
3.83 ± 0.26 
 
 
Metabolizable 
Energy (kcal) 
 
 
11.51 ± 0.74 
 
12.53 ± 0.49 
 
12.53 ± 0.69 
 
 
12.51 ± 0.48 
 
11.55 ± 0.52 
 
11.56 ± 0.49 
 
Total Activity 
 
 
9986 ± 550 
 
7709 ± 356# 
 
7176 ± 401# 
 
10146 ± 671 
 
7401 ± 266# 
 
7383 ± 435# 
 
Dual Beam 
Activity 
 
 
3351 ± 405 
 
2707 ± 124# 
 
2429 ± 187# 
 
3125 ± 359 
 
2505 ± 136# 
 
2341 ± 109# 
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Waking VO2 
(ml O2/hr) 
 
106 ± 3.0 
 
117 ± 2.1# 
 
118 ± 4.7# 
 
107 ± 3.2 
 
121 ± 2.6# 
 
119 ± 3.6# 
 
Sleeping VO2 
(ml O2/hr) 
 
 
83 ± 3.0 
 
92 ± 2.4# 
 
89 ± 4.4# 
 
85 ± 2.2 
 
94.2 ± 2.6# 
 
92 ± 3.9# 
 
Daily VO2 
(ml O2/hr) 
 
 
98 ± 2.5 
 
110 ± 3.0# 
 
106 ± 4.2# 
 
100 ± 3.3 
 
114 ± 2.4# 
 
110 ± 3.5# 
 
Awake RER 
 
 
0.927 ± 0.009 
 
0.926 ± 0.007 
 
0.908 ± 0.006 
 
0.934 ± 0.01 
 
 
0.941 ± 0.005 
 
0.908 ± 0.01 
 
Sleep RER 
 
 
0.899 ± 0.012 
 
0.890 ± 0.007 
 
0.888 ± 0.009 
 
0.893 ± 0.011 
 
0.899 ± 0.008 
 
0.875 ± 0.014 
 
Total RER 
 
0.912 ± 0.01 
 
0.904 ± 0.006 
 
0.893 ± 0.005 
 
0.923 ± 0.007 
 
0.910 ± 0.007 
 
0.901 ± 0.006 
 
       
Main effect of age (Pre < Post) for Body Weight (P<.0001). Main effect of genotype (mdx > WT & mdx/Sln-null) for relative total daily 
VO2 (P < 0.05), relative waking VO2 (P < 0.05), and relative sleeping VO2 (P < 0.05). Main effect of genotype (mdx & mdx/Sln-null > 
WT) for absolute total daily VO2 (P < 0.05), absolute waking VO2 (P < 0.05), and absolute sleeping VO2 (P < 0.05). *Significantly 
different from Pre (P<0.05). #Significantly different from WT. $ Significantly different than mdx. VO2, oxygen consumption, RER, 
r e s p i r a to r y ex ch ange  r a t i o .  V a l u es  a re  M ean  ±  S E M ( WT :  n  =  11 ,  mdx :  n  =  1 3 ,  m d x / S l n -n u l l ;  n  =  8 ) 
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Appendix B: Product Sheet of Mice Chow Diet 
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Appendix C: Product Sheet of High Fat Diet 
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Appendix C: Product Sheet of High Fat Diet 
 
